Jnj 50 Jours De Moyenne Mobile

Actualités de la Bourse de New York Analyse des amplificateurs en temps réel après les heures Pré-marché Actualités Citation Flash Résumé Citation Graphiques interactifs Réglage par défaut Veuillez noter qu'une fois votre sélection effectuée, elle s'appliquera à toutes les futures visites au NASDAQ. Si, à tout moment, vous êtes intéressé à revenir à nos paramètres par défaut, sélectionnez Réglage par défaut ci-dessus. Si vous avez des questions ou rencontrez des problèmes lors de la modification de vos paramètres par défaut, envoyez un courriel à isfeedbacknasdaq. Veuillez confirmer votre sélection: Vous avez choisi de modifier votre paramètre par défaut pour la recherche de devis. Ce sera maintenant votre page cible par défaut à moins que vous changiez votre configuration à nouveau, ou que vous supprimez vos cookies. Voulez-vous vraiment modifier vos paramètres? Nous avons une faveur à vous demander. Veuillez désactiver votre blocage d'annonce (ou mettre à jour vos paramètres afin de vous assurer que les cookies et les javascript sont activés) afin que nous puissions continuer à vous fournir les nouvelles de premier ordre Et les données que vous venez d'attendre de nous.3: 43 heures Omnicom filiale DDB San Francisco nommé partenaire marketing principal pour le programme Energy Upgrade Californie de la California Public Utilities Commission travaux prévus pour le lancement d'avril 2017 (OMC). 3:29 pm PGampE permettra d'éliminer environ 450 emplois de services de soutien co a également éliminé les rôles d'environ 800 entrepreneurs non salariés de l'ensemble de la société (PCG). Ces réductions de coûts projetées ont été reflétées dans les lignes directrices fournies lors de son appel au bénéfice du troisième trimestre tenu le 4 novembre 2016. La majorité des réductions de coûts proviendront de réductions des dépenses de matériaux et de contrats, de renégociation des contrats avec les fournisseurs et de réduction des dépenses pour les professionnels Les services et les dépenses discrétionnaires. 3:18 pm Areva SA a confirmé l'approbation de la CE pour l'exécution des augmentations de capital d'AREVA SA et NewCO (ARVCF). Assemblée Générale des actionnaires d'AREVA SA et de NewCo ont confirmé, le 3 février 2017, statuer sur les augmentations de capital respectives suite à l'approbation de la Commission européenne. Prix ​​d'émission des nouvelles actions d'AREVA SA fixé à 4,50 par action, en cohérence avec le cours d'une Offre Publique d'Achat d'Actions AREVA SA (suivie, le cas échéant, d'un retrait obligatoire) qui serait déposée par l'Etat, Une fois l'augmentation de capital de NewCo réalisée. Exécution des augmentations de capital une fois les conditions préalables de la Commission européenne remplies. Octroi d'avances sur le compte courant des actionnaires par l'Etat français pour assurer la liquidité des Groupes jusqu'à l'exécution des augmentations de capital. La société EURA est en train de finaliser les discussions avec ses partenaires bancaires afin d'obtenir, d'une part, les accords nécessaires pour procéder à l'augmentation de capital de NewCo Et, d'autre part, un prêt-relais de 300 millions d'euros pour fournir des liquidités supplémentaires à AREVA SA au cas où la vente de New NP serait retardée à la fin de 2017. 15h14 Lockheed Martins Sikorsky a remporté le contrat Pour la phase 3 de la Défense Projets de recherche avancée Agences (: DARPA) Aircrew Labor In-Cockpit AutomatION SYSTEM PROGRAMME (LMT). 3:12 pm Fiat Chrysler nommé Daphne Zheng COO de la Chine et Paul Alcala COO de AsiA RÉGIONS DU PACIFIQUE (EXCLUANT LA CHINE) (FCAU). Mike Manley, qui a dirigé la région Asie-Pacifique jusqu'à maintenant, continuera de servir sur le GEC et en tant que chef des marques Jeep et Ram dans le monde. 2:39 pm Eaton Vance autorise le rachat d'un maximum de 8 millions d'actions. DÉCLARAIT également UNCHANGED 0.28SHARE DIVIDENDE TRIMESTRIEL (EV). 13 h 22 Nexstar confirme que la FCC a ACHETÉ LES DEMANDES ET DEMANDES DE RENONCIATION LIEES PAR MEDIA GENERAL (MEG) en outre, la FCC a renoncé à l'interdiction de consommer la transaction, qui reste en vigueur (NXST). 1:12 pm EnerJex Resources reçoit une lettre de non-conformité de la NYSE PAR RAISON DE SA NON-RESPONSABILITÉ D'ASSURER UNE ASSEMBLÉE ANNUELLE POUR L'EXERCICE TERMINÉ LE 31 DÉCEMBRE 2015 (ENRJ). 1:01 PM LE GROUPE WILLDAN REÇOIT UN NOUVEAU CONTRAT DE BASE DE TROIS ANS DE 75 MILLIONS DE DOLLARS POUR MISE EN ŒUVRE DE CON EDISON (ED) du programme d'installation directe commerciale de New York dans les services publics de New York et de Westchester. Ce nouveau programme remplace et élargit le programme d'installation directe Con Edisons Small Business, que Willdan a mis en place depuis 2009, en augmentant la taille des clients commerciaux admissibles et en diversifiant les offres de programmes. Willdan s'attend à ce qu'il y ait des ajouts au contrat de base, qui se poursuivra jusqu'à la fin de 2019. Le contrat de base ne comprend pas le programme de voisinage de Brooklyn, les expansions décrites dans le projet de taux de règlement conjoint ou les domaines de programme supplémentaires. 1:00 pm Sommaire du marché de midi: Le marché boursier est modérément plus bas à la mi-journée (: WRAPX): Les actions sont légèrement plus basses cet après-midi avec le SampP 500 affichant une perte de 0,2. La moyenne industrielle Dow Jones (0,1) surperforme, le commerce juste au-dessus de sa ligne plate. La session d'aujourd'hui a commencé avec quelques nouvelles d'entreprise mélangées. Signet Jewelers (SIG 84.15, -3.31) a baissé de 3,8 après que la société a réduit ses résultats du quatrième trimestre par action et les gammes de ventes de même-magasin de guidage sur le dos de quelques ventes de vacances faible. Ford Moteur (F 12.61, -0.24) est également cocher plus bas, perdre 1.8, en dépit de l'orientation en ligne ce matin. À l'inverse, United Continental (UAL 75,60, 1,94) est plus élevé de 2,7 après que la société a relevé ses prévisions de recettes unitaires pour le quatrième trimestre. Toutefois, le plus gros moteur du marché a été président-élu Trumps conférence de nouvelles, qui a pris fin il n'y a pas longtemps. La plupart des secteurs restent proches de leurs lignes planes alors que les investisseurs digèrent la conférence de presse, qui a été brève sur les détails concernant les dépenses d'infrastructure prévues. Les services financiers, les biens de consommation discrétionnaire, les produits industriels, les matériaux, la technologie, les biens de consommation courante et le commerce immobilier se situent à moins de 0,2 de leurs lignes planes respectives. M. Trump a exprimé le désir de ramener les opérations pharmaceutiques aux États-Unis et a exprimé son soutien à l'enchère concurrentielle des prix des médicaments. La biotechnologie a plongé en conséquence, comme en témoigne la baisse de 3,3% du FNB iShares Nasdaq Biotechnology (IBB 277,44, -9,06). Le secteur des soins de santé (-1,7) est également en baisse, tombant au bas du classement. En revanche, le secteur de l'énergie (1.1) conduit ses concurrents, sur une performance positive du pétrole brut. La marchandise continue à augmenter, en hausse de 3,3 à 52,46bbl, malgré les données de l'EIA montrant des stocks d'inventaire notables sur tous les fronts. Le secteur des services publics (0,5) est le seul autre espace de façon convaincante dans le vert. Les Treasuries américains ont vu un léger remontée de l'intérêt d'achat à la suite de la conférence de presse de M. Trumps. Le rendement de 10 ans est en baisse de deux points de base à 2,36. A noter également que l'indice du dollar des États-Unis (101,93, -0,08) est revenu à inchangé après avoir affiché un gain massif dans l'action du matin. Les données économiques d'aujourd'hui seulement étaient l'index de prêt hypothécaire de MBA, qui a traversé les FILS À 7:00 AM ET CE MATIN. L 'INDEX EST DANS LA LIGNE 5.8. 12:53 PM FINISH LINE ACCROIT DIVIDENDE TRIMESTRIEL À 0.11SHARE DE 0.10SHARE (FINL). 12 h 30 Medovex ENTRE DANS UN ACCORD DE DISTRIBUTION AVEC ALFAMED S. R.L. UN FOURNISSEUR D'ÉQUIPEMENTS INNOVANTS DE CHIRURGIE SPINIQUE COUVRE LA DISTRIBUTION DE SON SYSTÈME DENERVEX DANS TOUTE L'ITALIE (MDVX). 12:20 pm Textron commence les essais sur l'eau pour la quatrième génération de véhicules de surface ordinaires non habités (TXT): «Nous sommes excités de commencer le test de niveau système de notre premier système UISS avec des capacités de contre-mesures de mine pour la marine américaine, dit le vice - Systèmes de contrôle et de surface Wayne Prender. La technologie de pointe de la quatrième génération CUSV de Textron Systems est un véhicule de surface non-piloté à plusieurs missions doté d'une grande capacité de transport configurable Charge utile. Depuis sa première manifestation en 2009, le CUSV a réussi plusieurs exercices importants avec la Marine américaine. 12:16 pm Calendrier des gains pour le mercredi 11 janvier (: SUMRX). Aujourd'hui, après la recherche rapprochée pour les entreprises suivantes de signaler: KBHTomorrow avant la recherche ouverte pour les entreprises suivantes à signaler: TSM, DAL, SJR, FCEL 12:03 PM KC Sud, WATCO, et WTC INDUSTRIAL ANNONCEZ UN INVESTISSEMENT JV QUI FACILITATE ET AMÉLIORER L'EXPORTATION DE COMBUSTIBLES LIQUIDES DES É.-U. AU MEXIQUE (KSU). Les partenaires de la coentreprise investiront environ 45 millions de dollars américains dans cette phase du projet, dont l'achèvement est prévu pour le deuxième trimestre de 2017. Il est prévu que le projet terminal inclura éventuellement une installation de stockage qui fournirait des carburants de détail à la population Du Mexique central. 11h55 Cours de clôture des marchés européens (: SUMRX). Les marchés européens sont désormais des marchés boursiers clôturés en Europe, comme suit: Royaume-Uni FTSE: 0,2 Allemand DAX: 0,5 Franc CAC: 0,0 Espagnes IBEX: -0,6 Portugals PSI: -0,6 Italys MIB Index: 0,3 Irlandais Ovrl Index: 0,3 Grèce ASE Index général: 0.4 11:42 am Discussion de plan: Poussée de prix (: TALKX): Les indices principaux ont poussé leurs sommets pour la journée pendant que la conférence de presse de Président-élu Trumps a commencé. Peu de temps après que le président élu a commencé ses remarques, les principaux indices ont roulé de façon uniforme, précipité par un commentaire du président élu Trump qu'il doit y avoir des offres plus concurrentielles de prix de drogue et que d'autres industries doivent également voir plus de concurrence. Le secteur des soins de santé (-1,7) a été un pionnier dans le retrait, comme la biotechnologie et les principaux stocks pharmaceutiques ont reculé sur le titre, mais la plupart des secteurs ont également réagi négativement. L'iShares Nasdaq Biotechnology Index (IBB 278.48, -8.02, -3.4) est un sous-performant notable. La conférence de presse est toujours en cours, bien que la négociation sur la nécessité d'accroître la concurrence pour réduire les dépenses gouvernementales souligne la sensibilité des marchés boursiers au risque politique majeur dans la transition vers une nouvelle administration. Les principaux indices sont tous à des niveaux inférieurs de session alors que l'indice des DOLLARS des États-Unis et la note de 10 ans indiquent que la période de poussée est élevée en raison d'une certaine activité d'aversion au risque. 11:37 AM LOCKHEED MARTIN GOULE À LA SUITE DES OBSERVATIONS DU PRÉSIDENT-ELECT DONALD TRUMP CONCERNANT LE PROGRAMME F-35 (LMT). 11:32 am Les stocks baissent à la session basse en tant que Président Élect Trump holDS PREMIÈRE CONFÉRENCE DE PRESSE SampP 500 -0,2 QQQ -0,3, DIA 0,1 (SPY). 11:10 am PTC Therapeutics étend sa force récente à 10 MOIS HAUTE PRÉSENTATION SUIVANTE À JPM HEALTHCARE CONFERENCE (PTCT). 11:05 am Réalité sociale annonce que SRAXmd a rapporté record record non audité en 2016 réservations pour Janvier 2017 sont en hausse de 100 vs Janvier 2016 (SRAX). La revue non audité de 2016 pour SRAXmd a augmenté de 90 yy à partir de 2015 et la revue non audité du quatrième trimestre pour SRAXmd en 2016 a dépassé la revue annuelle totale enregistrée pour SRAXmd en 2015 avec une croissance ay non audité de 85 yy pour le quatrième trimestre. Sur la base de l'information financière préliminaire non vérifiée, la ligne de produits SRAXMD a terminé l'année avec 2016 REV up 115 par rapport à REV ACCRUED en 2015. 11h01 SINCLAIR BROADCAST COMMENTAIRES SUR RAPPORTS RÉCENTS RELATIFS À SA COUVERTURE POLITIQUE DES CAMPAGNES PRESIDENTIELLES APPELLE LE POSTE DE WASHINGTON UNE FOIS (SBGI): Extrait de l'Op-Ed de la Société soumis au Washington Post, que la Poste a refusé de publier. Votre pièce sur la couverture politique de Sinclairs était trompeuse et irresponsable. Beaucoup de faits importants ont été omis, les faits que votre journal était au courant et a refusé d'inclure dans l'article. Votre histoire a été largement basée sur les détails publiés dans un article Politico de la semaine précédente. Sinclair est allé au-delà avec des offres d'entrevue pour les deux campagnes. Il s'agissait d'un projet pleinement transparent appelé quanBeyond the Podiumquot, où les candidats pouvaient parler directement et longuement aux téléspectateurs sur des sujets clés. Le simple fait est qu'un candidat a profité de cette offre et l'autre n'a pas. NOUS AVONS FAIT UN POINT D'AVOIR UN PAROLE DE PARTI DÉMOCRATIQUE OU DE CLINTON SURROGATE CHAQUE SEMAINE. TOUS CES DÉTAILS ONT ÉTÉ IGNORÉS EN FAVEUR D'UNE HISTOIRE PLUS SALACIEUSE DE L'INTRIGUE ET DE LA CONSPIRATION. quot 11h01 La General Comm acquiert les termes de Northpoint Consulting non divulgués (GNCMA). Northpoint fournit des services de conseil tels que l'analyse et la sécurité des réseaux, la gestion de la migration des nuages ​​et la conception des communications, à bon nombre des entreprises Fortune 500 du pays. 10:51 Moteurs remarquables d'intérêt MSM 7.7 sur Q1 EPS battre, Q2 orientation (SCANX): Voici quelques-uns des plus remarquables déménageurs d'intérêt, catégorisés par capitalisation boursière (grande capitalisation plus de 10 milliards de dollars et moyenne cap entre 2-10 Milliards) et classés par changement (tous les stocks de plus de 100K volume quotidien moyen). Large Cap Gainers WDAY (80,48 8,24): Plus élevé après les faits saillants d'analystes vendant côté traitent avec grand client. MRK (62.99 5.12): Reçoit l'acceptation par la FDA d'une demande de licence biologique supplémentaire pour Keytruda en combinaison avec la chimiothérapie pour le traitement de première intention du cancer du poumon non à petites cellules non squameux métastatique. UAL (76,51 3,87): Attend que le chiffre d'affaires consolidé de l'unité passagers Q416 diminue de 1,25 à 1,75 (avant 3-4) par rapport au 4e trimestre. Les perdants à grande capitalisation JNPR (27,84 -1.99): Downgraded to Sell from Hold à la Deutsche Bank. EQT (62,58 -1,2): Downgraded to Market Perform à partir du rendement supérieur de BMO Capital. Mid Cap Gainers MSM (99,31 7,74): Rapporte le rythme de l'EPS du premier trimestre, ce qui guide le BPA du 2e trimestre au-dessus du consensus. GMED (26,73,57): rapporte les ventes préliminaires du quatrième trimestre au-dessus du consensus et publie les lignes directrices de l'exercice 17 en ligne. Pertes de capitalisation moyenne NICE (66,47 -4,03): Attend que Q4 et FY16 revEPS soit au-dessus ou au-dessus du point médian de l'orientation précédente, autorise un nouvel ampli élargi 150 mln programme de rachat d'actions, élimine dividendes débutant 1Q17, amp COMMENCES 225 MLN OFFRE PRIVÉE NOTES EXCHANGEABLES DONT 2024. VIPS (11.07 -4.24): INITIÉ AVEC UNE SOUS-COUPE À BERNSTEIN TGT 10. 10:45 AM CADENCE DESIGN ANNONCE QUE ALTASENS A ADOPTE LA SOLUTION DE TEST CADENCE MODUS POUR SES SIGNES D'IMAGE NEXT-GENERATION SIGNAL MIXTE (CDNS ). 10:20 am Énergie, transports, forte dans le début du commerce avec les métaux, la vente au détail et le retard bitoech vs SPY 0.1 (SPY). USO 1,25 UUP 0,89 IYT 0,62 OIH 0,58 HACK 0,47 DIA 0,28 XOP 0,17SLV -1,32 XME -0,92 XRT -0,89 GLD -0,77 XBI -0,59 IBB -0,42 XLRE -0,36 9:44 am Résumé d'ouverture du marché: Le marché boursier s'ouvre (WRAPX ): Les actions ont ouvert la séance d'aujourd'hui avec le SampP 500 inchangé depuis le niveau de clôture hier. Le Dow surperforme légèrement avec un gain de 0,1. Le secteur des services publics (0,3) a pris la tête tôt, suivi par des gains modestes des soins de santé (0,2) et des biens de consommation de base (0,1). A l'inverse, TELECOM SERVICES (-0,9), FINANCIER (-0,4) ET IMMOBILIER (-0,2) SONT FONDS DU LEADERBOARD. LE SECTEUR DE LA TECHNOLOGIE À PONDÉRATION SUPÉRIEURE (UNCH) FONCTIONNE AVEC SA PLATE-FORME. LES TRÉSORÉS SONT EGALEMENT PLATS DANS L'ACTION PRÉCOCE. LE RENDEMENT DE 10 ANS EST INCHANGE A 2.38. 9:40 AM PRIX DE CROISSANCE RÉSIDENTIELLE BLUEROCK 4 MLN STOCK COMMERCIAL OFFRANT À 13.15SHARE --SHARES HALTED-- (BRG). 9:29 am Sur les fils (: FILS). XPO Logistics, Inc. (XPO) a reçu un contrat de la chaîne d'approvisionnement de Cummins Inc. (CMI), un leader mondial de l'énergie, pour soutenir ses clients dans le monde entier. XPO Logistics exploitera le centre de distribution de pièces primaires Cummins à partir de ce mois, gérant environ 800 travailleurs et plus de 2 700 commandes expédiées quotidiennement. La géothermie américaine (HTM) a annoncé que l'estimation de la capacité de réservoir géothermique associée à son projet San Emidio II est passée de l'estimation précédente de 10 mégawatts nets à une capacité estimée de 47 mégawatts nets. Hortonworks (HDP) a annoncé une collaboration en technologie open source avec Neustar (NSR) pour créer des outils de sécurité et de gestion de l'identité pour les périphériques IoT. Le grand service coréen Fournisseur LG U (membre du groupe LG) a sélectionné la technologie Juniper Networks (JNPR) pour sa mise à niveau de réseau 5G de prochaine génération, qui comprend la capacité de réflecteur d'itinéraires virtuels Juniper Networks dans le vMX et les commutateurs Ethernet EX4300EX2200.JetBlue (JBLU ) A annoncé sa toute dernière amélioration à bord: une connectivité Wi-Fi toujours gratuite sur tous les avions, de la porte de départ à la porte d'arrivée. Perry Ellis International (PERY) a conclu une entente de licence avec Euroneck, SA de CV pour concevoir et distribuer des cravates pour hommes, des nœuds papillon, des caleçons, des pochettes, des ascots, des foulards d'hiver et d'été et des bonneteries sous les marques Perry Ellis et John Henry au Mexique . Mentor Graphics Corp. (MENT) a annoncé que TSMC (TSM) a étendu sa collaboration avec Mentor Graphics sur la plate-forme Xpedition Enterprise en conjonction avec la plate - Caliber pour la conception et la vérification de la technologie d'emballage InFO (Integrated Fan-Out) TSMC pour les applications d'intégration multi-puce et DRAM. Mentor a développé de nouvelles fonctionnalités Xpedition spécifiquement pour prendre en charge l'InFO et permettre au concepteur de packages IC de terminer les tâches de conception selon les spécifications TSMC. En exploitant les capacités des technologies Caliber et HyperLynx, la nouvelle fonctionnalité Xpedition minimise les efforts de conception et les cycles de vérification des règles de conception nécessaires pour obtenir un fichier GDS InFO propre à la DRC. Verizon (VZ) a complété ce qu'il considère être le premier essai d'interopérabilité de NG-PON2 (nouvelle génération de réseau optique passif). ADTRAN (ADTN) a participé à Verizons récent essai d'interopérabilité de la technologie NG-PON2. L'essai, qui comportait plusieurs fournisseurs de technologies différentes et était aligné sur la spécification Verizons Open OMCI, a prouvé que les solutions multi-fournisseurs pour la terminaison de ligne optique sur le fournisseur de services et le terminal de réseau optique sur le client peuvent augmenter considérablement la bande passante livrée Sans affecter les abonnés à haut débit existants sur la même ligne de fibre optique. Cet essai met également en évidence l'amélioration de l'évolutivité du service et l'élasticité opérationnelle que fournit NG-PON2. Ceci inclut le plus haut niveau de flexibilité de bande passante, maximisant l'automatisation du réseau SDNNFV et permettant la création et la livraison rapides de services à la clientèle. Ericsson (ERIC) et Cisco (CSCO) étendent leur partenariat stratégique pour inclure une nouvelle solution Wi-Fi, Réseaux Wi-Fi évolués. EWN combine l'accès Ericssons 3GPP, les réseaux de base et les applications avec le portefeuille Cisco Cisco, pour fournir une connexion Wi-Fi fiable aux performances les plus élevées pour les clients mobiles, câblés et autres industries d'Ericssons. La Bourse de New York, qui fait partie d'Intercontinental Exchange (ICE), a annoncé son intention d'étendre ses opérations de négoce au sol, offrant ainsi aux investisseurs un accès encore plus important à tous les titres américains pour la première fois avec un modèle de marché unique et éprouvé. (DFS) et PayPal (PYPL) ont signé un accord rendant PayPal plus largement disponible pour découvrir les titulaires de carte, les acquéreurs et les commerçants. Paice a conclu un accord de règlement avec VOLKSWAGEN (VLKAY), AUDI (AUDVF) et PORSCHE (POAHY) concernant PAICES HYBRID VEHICLE BREVETS. LES CONDITIONS DE L'ACCORD SONT CONFIDENTIELLES. L'ACCORD MET FIN À TOUTES LES QUESTIONS JURIDIQUES PENDANTES ENTRE LES SOCIÉTÉS. PAICE ET LA FONDATION D'ABELL ONT DÉPOSÉ UNE PLAINTE CONTRE LES INFRACTIONS EN MATIÈRE DE BREVETS AVEC LA COMMISSION DU COMMERCE INTERNATIONAL (ITC) des États-Unis en avril 2016. Une audition à l'ITC était prévue pour janvier 2017. 9:18 am Terreno Realty signale son activité d'exploitation, Pour le 4T16 (TRNO): Au 31 décembre 2016, Terreno Realty Corporation possédait 166 immeubles totalisant 12,0 millions de pieds carrés et cinq parcelles améliorées de 22,8 acres. Les principales mesures d'exploitation étaient les suivantes: Le portefeuille total était de 97,4 loués à 376 locataires contre 96,4 au 30 septembre 2016 et 91,5 au 31 décembre 2015 Le même portefeuille de magasins de 8,6 millions de pieds carrés était 99,0 loué au 31 décembre 2016 comme Comparativement à 97,9 au 30 septembre 2016 et 92,6 au 31 décembre 2015 Les loyers de cessions de nouveaux et renouvelés pour un total de 0,6 million de pieds carrés s'accélèrent au cours du quatrième trimestre et ont augmenté de 1,8 million de pieds carrés au cours des douze mois terminés le 31 décembre 2016 augmenté de 19,2 . 9:16 NUMEREX CORP. TERMINE L'EMPLOI DE MARC ZIONTS COMME DIRECTEUR GÉNÉRAL Le directeur général KENNETH GAYRON ASSUME LE RÔLE ADDITIONNEL DES NOMS DE DIRIGEANTS INTERMÉDIAIRES KELLY GAY COMME LE COO ANTICIPE LE REVENU AMÉLIORERA SUR UNE BASE DE YY LA PROCHAINE ANNÉE (NMRX). M. Zionts n'était pas lié à une comptabilité de la Société, à des contrôles internes ou à des rapports financiers. Kenneth Gayron, le chef des finances, assumera le rôle supplémentaire de chef de la direction intérimaire travaillant en étroite collaboration avec le conseil tout en effectuant une recherche Pour un PDG permanent. En outre, Kelly Gay a accepté de rejoindre Numerex en tant que chef de l'exploitation et travaillera en étroite collaboration avec Ken pour gérer la gamme de solutions de sécurité et IoT de la société et diversifier la base de clients. Gays a déjà travaillé sur la sécurité de Numerexs et les lignes de produits judiciaires en tant que président de Solutions de sécurité, et elle a contribué à plusieurs initiatives stratégiques de la société. La Société devrait améliorer considérablement son EBITDA sur 2016 avec des estimations du BAIIA ajusté allant de 8,5 millions à 10 millions. On s'attend à ce que les revenus augmentent d'année en année. La Société fournira une estimation des prévisions de revenus pour l'ensemble de l'exercice à l'issue de la prochaine conférence téléphonique sur les résultats prévus. 9h14 SampP futures vs juste valeur: 1,50. Nasdaq à terme à la juste valeur: 4,80. (: WRAPX): Le marché boursier est prêt pour un légèrement plus ouvert que le SampP 500 futures échanges deux points au-dessus de la juste valeur. Le pétrole brut est en hausse pour la première fois en trois jours, au milieu de rapports selon lesquels l'Arabie saoudite, premier exportateur mondial, prévoit de réduire l'offre en Asie. Le produit est plus élevé de 0,4, à 51,03bbl. Sur le front corporatif, United Continental (UAL 75,00, 1,34) est plus haut de 1,8 dans le commerce avant la mise sur le marché après que la compagnie a relevé ses directives de revenu unitaires du quatrième trimestre. À l'inverse, Ford Motor (F 12.75, -0.10) est en baisse de 0.8 malgré la réaffirmation de ses prévisions de profit avant impôt ajustées pour 2016 et sa conviction que le bénéfice avant impôt ajusté en 2017 sera légèrement inférieur à 2016. Signet Jewellers (SIG 83.90 , -3,56) est également en baisse, perdant 4,1, après que la société a réduit ses bénéfices du quatrième trimestre par action et les gammes de guides de vente sur les mêmes magasins, à la suite de quelques ventes faibles de vacances. Les bons du Trésor des États-Unis ont connu une légère hausse dans l'achat d'intérêts avec le rendement de 10 ans en baisse d'un point de base à 2,37. A noter également que l'indice Dollar des États-Unis (102,39, 0,38) est plus élevé de 0,4 en raison de la faiblesse de l'euro (1,0513) et du yen japonais (116,19). Bien qu'il n'y ait pas de grands RAPPORTS économiques aujourd'hui, PRESIDENT-ELECT TRUMPS quotgeneral news conferencequot est susceptible d'être scruté par les investisseurs. M. Trump doit parler du lobby de la Trump Tower à 11 h HE. 9h09 US Geothermal annonce que l'estimation de la capacité de réservoir géothermique associée à son projet San Emidio II est passée de l'estimation précédente de 10 mégawatts nets à une capacité estimée de 47 mégawatts nets. Co déclare: «Ayant la capacité d'ajouter une plus grande centrale électrique à notre complexe San Emidio, nous allons réduire les coûts d'investissement et d'exploitation et nous donner un projet très compétitif sur le plan des coûts. De plus, cela nous permettra de déployer deux, voire trois, des centrales déjà acquises dont nous avions annoncé l'acquisition au début de 2016.Quote de 9:07 am Intuitive Surgical issues upside prelim Q4 sales (ISRG). En 2016, environ 753 000 interventions chirurgicales ont été réalisées avec le système chirurgical Da Vinci, soit une augmentation d'environ 15 comparativement à environ 652 000 interventions effectuées en 2015. La croissance du volume de la procédure globale en 2016 a été Principalement en raison de la croissance des procédures de chirurgie générale aux États-Unis et des procédures urologiques à l'échelle mondiale. Da Vinci ont augmenté d'environ 15 pour le quatrième trimestre de 2016 par rapport au quatrième trimestre de 2015. La société prévoit que les procédures totales de Da Vinci croîtront d'environ 9 à 12 en 2017. Nous sommes satisfaits de nos résultats du quatrième trimestre et encouragés par nos OPPORTUNITÉS . EN 2017, NOUS AVONS VISITER AVANCER PLUSIEURS INNOVATIONS DE DÉVELOPPEMENT DE PRODUITS CLÉS VISANT À AMÉLIORER LES RÉSULTATS DES PATIENTS ET À ÉVALUER LE NOMBRE DE PATIENTS QUI PEUVENT DERIVER LES BÉNÉFICES DES THÉRAPIES MINIMALEMENT INVASIVES ROBOTIQUEMENT ASSISES DANS LE MONDE. Endurance International annonce que Google (GOOGL) Domains a choisi sa marque Bluehost pour fournir des solutions d'hébergement WordPress aux nouveaux clients existants (EIGI) . 9:05 am McClatchy pour vendre Amp lease de retour biens immobiliers appartenant à The Sacramento Bee à Sacramento, en Californie et The State Media Company en Caroline du Sud pour 67,8 mln (MNI). Ces transactions sont soumises aux conditions habituelles de clôture et devraient être clôturées au deuxième trimestre de 2017.A la clôture des transactions, la société est tenue de proposer d'abord le produit après impôts des ventes au pair aux porteurs d'obligations garanties conformément à L'emprunt pour ses obligations garanties de 9,0 échéant en 2022. Aux termes de l'acte de fiducie pour ses obligations non garanties, la société dispose de 90 jours civils pour réduire sa dette d'environ 48,0 millions (sous réserve de changement de capital au moment de la clôture des opérations) RÉFLÈTE LA DETTE ATTRIBUABLE ASSOCIÉE AUX LOCAUX. SI LES PORTEURS DE TITRES SÉCURISÉS DEVRAIENT NE PAS PARTICIPER À L'OFFRE PAR, LA SOCIÉTÉ PEUT ENTRAÎNER LA RÉDUCTION DE CERTAINS DE SES OBLIGATIONS NON CONÇUES AVEC LES PRODUITS APRÈS-TAXES POUR RÉPONDRE À SON EXIGENCE DURANT 90 JOURS DE CALENDRIER POUR RÉDUIRE LA DETTE. 9:03 AM KLX ANNONCE DE NOUVEAUX PRIX D'AFFAIRES POUR SES SOLUTIONS AÉROSPATIALES GROUPE D'AFFAIRES ÉVALUÉ À APPROX. 300 MLN DANS L'AGREGAT (KLXI). Co indique, comme indiqué sur notre plus récent appel de revenus, ces nouveaux prix de programme étaient en cours de négociation au cours du quatrième trimestre et ont maintenant été officiellement attribués à KLX. Ces nouveaux programmes devraient générer environ 60 millions par an de revenus annuels additionnels après une période de transition de 12 mois. 9 h 03 Landauer annonce un accord avec Gilead Capital, accepte de nommer son Chief Investment Officer, Managing Partner et Co-Founder Jeffrey A. Strong au Conseil (LDR). La nomination de Strongs s'inscrit dans le cadre d'un accord avec Gilead Capital LP, dans le cadre duquel Gilead a accepté de retirer son ardoise des administrateurs aux élections lors de l'assemblée annuelle de 2017, de voter pour tous les administrateurs-fondateurs et d'autres provisions de stand. EN VERTU DE L'ACCORD AVEC GILEAD, LA SOCIÉTÉ A ÉGALEMENT CONVENU DE NOMINER UN NOUVEAU DIRECTEUR INDÉPENDANT MUTUELLEMENT AGREEABLE AVEC GILEAD POUR L'ÉLECTION À L'ASSEMBLÉE ANNUELLE DES ACTIONNAIRES DE 2018 9h03 L'ACTIONNAIRE D'IMMUNOMEDICS VENBIO ENVOIE UNE LETTRE AU CONSEIL D'IMMU ANNULE 4 CANDIDATS POUR L'ÉLECTION AU CONSEIL DE LA COS À LA PROCHAINE RÉUNION ANNUELLE DE 2016 (IMMU): Points saillants de la lettre (comme indiqué par le conseiller venBio Select): croit qu'il est urgent de changer pour créer une valeur soutenue pour les actionnaires et les entreprises stratégiques qui échouent. IMMU-132 CANDIDAT AUX MÉDICAMENTS POUR LE CANCER DU CANCER DU CANCER TRIPLE NEGATIF ​​NE DOIT PAS ÊTRE DISTROTÉ PAR DES ANNONCES RÉACTIVES RÉCENTES DE LA SOCIÉTÉ, Y COMPRIS LES NOUVEAUX NOMINATEURS DU CONSEIL D'ADMINISTRATION DE VENBIOS - EN CONTRASTE AUX CANDIDATS DES ENTREPRISES - POSSEDENT LA DURÉE EXPÉRIENCE ET LA CAPACITÉ DE LIVRER LE TRAITEMENT IMPORTANT OPTIONS POUR LES PATIENTS. URGES LES ACTIONNAIRES DE VOTER POUR VENBIOS QUATRE NOMINES SUR LA CARTE PROXY OR. 9:01 AM BELDEN ET CORNING (GLW) ANNONCENT UNE COLLABORATION TECHNIQUE DANS LE DOMAINE DE LA CONNECTIVITÉ DE LA LARGE BANDE DÉCIDE DE CONTREFAÇON DE BREVETS ET DE PROCÉDURES CONNEXES ENTRE LES RENSEIGNEMENTS RELATIFS AUX SORTIES CO. Nous nous attendons à ce que les tendances macroéconomiques permettant la croissance de cette technologie de continuer à l'avenir, comme l'intensité de bande passante, le cloud computing, et le nombre de périphériques connectés à l'Internet continuent à croître exponentiellement. quot 9:01 am Vertex Pharma 4 licences de recherche en oncologie programmes de développement À Merck KGaA (MKGAY) pour un paiement initial de 230 mln plus les redevances sur les ventes à terme (VRTX): avec cet accord stratégique, nous renforçons de façon significative notre pipeline oncologie dans deux domaines attrayants où nous avons des compétences de premier plan et la réparation et IMMUNO - ONCOLOGIE - DOMAINES QUI ONT AUSSI UNE SYNERGIE THERAPEUTIQUE PROMETTEE, a déclaré Belen Garijo, CEO Healthcare et Membre du Directoire de Merck KGaA, Darmstadt, Allemagne. Cette entente souligne notre engagement à accélérer l'innovation pour les patients atteints de cancer et nous sommes ravis de l'occasion de s'appuyer sur la science rigoureuse Vertexs et de promouvoir ces programmes de premier plan. Les deux programmes cliniques représentent des approches de premier ordre pour inhiber la réparation de l'ADN Pathologies qui sont fondamentales pour la survie et la prolifération de certains cancers: Un ataxie télangiectasie et un programme d'inhibiteur de la protéine kinase liée à Rad3 (ATR) composé de deux composés, VX-970 et VX-803. Le VX-970 fait l'objet d'une vaste enquête dans le cadre de 10 essais en cours sur les phases 1 et 2 sur une variété de tumeurs et de sous-types de patients qui devraient répondre à l'inhibition de l'ATR basée sur les données des biomarqueurs. Les données cliniques préliminaires du VX-970 ont été présentées lors de la réunion annuelle de l'American Society of Clinical Oncology (ASCO) de 2016 et de l'assemblée annuelle de l'American Association for Cancer Research (AACR) de 2016. VX-803 est un inhibiteur de l'ATR administré par voie orale actuellement dans les essais de phase 1 évaluant les doses croissantes de VX-803 seul et en combinaison avec la chimiothérapie. Programme d'inhibiteur de la protéine kinase (ADN-PK) dépendante de l'ADN incluant le candidat clinique VX-984. Un essai de phase 1 évalue maintenant les doses croissantes de VX-984 seul et en combinaison avec la doxorubicine liposomique pégylée chez les sujets atteints de tumeurs solides avancées. Merck KGaA, Darmstadt, Allemagne combinera ces actifs avec ses actifs DNA-PK existants dans un seul programme de développement. La collaboration et le paiement initial de 230 millions de francs sont soumis à l'expiration de la période d'attente de Hart-Scott-Rodino Loi sur les améliorations antitrust. 8:57 am Sur les fils (: FILS). Hemispherx Biopharma (HEB) a annoncé que le rintatolimod européen programme d'accès précoce conçu pour permettre l'accès du composé aux patients MECFS a été étendue aux patients atteints de cancer du pancréas à partir des Pays-Bas. Le premier patient a été dosé et plusieurs autres patients sont dans la file d'attente pour recevoir rintatolimod. MyTomorrows, le fournisseur exclusif de services Hemispherx en Europe et en Turquie, gérera toutes les activités EAP liées à l'extension en plus de ses activités existantes concernant l'utilisation d'accès précoce chez les patients souffrant de syndrome de fatigue chronique. 15 millions de financement. À ce jour, la société a recueilli plus de 50 millions d'euros. Participent à la ronde de financement actuelle sont un certain nombre d'investisseurs stratégiques: Samsung (SSNLF) Ventures, Foxconn (FXCNY), Taiwans MediaTek, et un tier-1 smartphone OEM. Deux fonds d'investissement supplémentaires ont participé à ce cycle de financement, l'un provenant de la Chine et l'autre de Hong Kong. Enel SpA (ENLAY), par l'entremise de sa filiale Enel Green Power North America, Inc. a acquis une participation de 100% dans Demand Energy Networks, Inc. a US-based company specialised in intelligent software and energy storage systems. Demand Energys core experience is in the behind-the-meter storage market. The company has carried out 24 projects since its creation, totalling 3 MW9 MWh of installed capacity in both the USA and Latin America, and boasts a pipeline in excess of 30 MW100 MWh. 8:52 am SampP futures vs fair value: -1.30. Nasdaq futures vs fair value: 1.00. (:WRAPX) : The SampP 500 futures trade one point below fair value. Markets in the Asia-Pacific region ended Wednesday on a mixed note, but the trading day was fairly quiet. The World Bank did lower its GDP growth outlook for 2017 and 2018, but the adjustment only reduced the previous forecast by 10 basis points. The forecast for 2017 was lowered to 2.7 from 2.8. The U. S. growth forecast for 2017 was maintained at 2.2 due to the expected impact of fiscal stimulus under the new administration. In economic data: Japans November Leading Index 102.7 (expected 102.6 previous 100.8). November Coincident Indicator 1.6 month-over-month (last 1.0) South Koreas December Unemployment Rate declined to 3.4 from 3.6. December Import Price Index 9.2 year-over-year (last 3.6) and December Export Price Index 6.3 year-over-year (last 3.5) ---Equity Markets--- Japans Nikkei added 0.3. Growth-sensitive names like SUMCO, Nippon Sheet Glass, Kobe Steel, Sumitomo Metal Mining, Japan Steel Works, Mitsubishi Materials, and Ebara posted gains between 2.0 and 4.4. Hong Kongs Hang Seng climbed 0.8 amid strength in property names and financials. Sino Land, New World Development, Hang Lung Properties, Cheung Kong Property Holdings, China Overseas, Bank of China, Ping An Insurance, and HSBC added between 0.8 and 3.8. China Unicom Hong Kong lagged for the second day in a row, falling 2.0. Chinas Shanghai Composite lost 0.8. Shang Gong Group, Tianjin Global Magnetic Card, Wuhan Hanshang, and Shen Ma Industry registered losses between 5.4 and 6.8. Indias Sensex added 0.9 with help from most components. Coal India spiked 5.4 while other growth-sensitive names like Tata Steel, Larsen amp Toubro, Power Grid, and MahindraampMahindra rallied between 1.3 and 4.0. Bajaj Auto was the weakest performer, falling 0.9. Major European indices trade slightly above their flat lines with Germanys DAX (0.3) showing relative strength. Although equity markets have maintained narrow ranges so far, the euro has retreated steadily, falling 0.5 against the dollar to 1.0508. The decline leaves the single currency in the bottom half of its trading range that dates back to early December. The British pound has also retreated against the dollar, surrendering 0.5 to 1.2121, despite above-consensus economic data. On balance, economic data received since the Brexit vote has been strong relative to expectations. In economic data: UKs November Industrial Production 2.1 month-over-month (expected 0.8 last -1.1) 2.0 year-over-year (consensus 0.6 previous -0.9). November Manufacturing Production 1.3 month-over-month (expected 0.5 last -1.0) 1.2 year-over-year (consensus 0.4 last -0.5). November Construction Output -0.2 month-over-month (expected 0.3 last -0.6) 1.5 year-over-year (consensus 2.0 previous 0.7). November trade deficit widened to GBP12.16 billion from GBP9.89 billion (expected deficit of GBP11.20 billion) Spains November Industrial Production 3.2 year-over-year (consensus 1.0 last 0.6) ---Equity Markets--- Germanys DAX is higher by 0.3 with heavyweights Volkswagen, Deutsche Bank, Daimler, and Merck among the leaders. The four names are up between 1.0 and 2.8. On the downside, Siemens and BMW are down 1.2 and 0.1, respectively. Frances CAC has added 0.1 amid relative strength in automakers. Peugeot and Renault hold respective gains of 3.4 and 0.5 while Michelin has added 1.3. Financials trade in the RED WITH BNP PARIBAS, SOCIETE GENERALE, AND CREDIT AGRICOLE DOWN BETWEEN 0.4 AND 0.6. UKS FTSE IS HIGHER BY 0.2 THANKS TO GAINS IN CONSUMER NAMES. DIXONS CARPHONE, SAINSBURY, MARKS amp SPENCER, AND UNILEVER SHOW GAINS BETWEEN 0.6 AND 3.4. SELECT FINANCIALS LAG WITH RBS, BARCLAYS, STANDARD LIFE, AND RSA INSURANCE DOWN BETWEEN 0.2 AND 2.0. ITALYS MIB HAS ADDED 0.1. FINANCIALS LIKE BANCO BPM, BANCA POP EMILIA ROMAGNA, UNICREDIT, MEDIOBANCA, AND INTESA SANPAOLO ARE DOWN BETWEEN 0.1 AND 2.7. 8:45 AM MAGNACHIP SEMI UPSIZES amp PRICES A 75 MLN 5.00 EXCHANGEABLE SENIOR NOTES OFFERING ( MX ). The notes will be exchangeable at the option of the holder into shares of the cos common stock at an initial exchange RATE OF 121.1387 SHARES OF COMMON STOCK PER 1,000 PRINCIPAL AMOUNT OF NOTES, WHICH IS EQUIVALENT TO AN EXCHANGE PRICE OF 8.26SHARE. THE NOTES WILL BEAR INTEREST AT A RATE OF 5.00YEAR, PAYABLE SEMI-ANNUALLY IN CASH, IN ARREARS, ON EACH MAR 1 AND SEPT 1, BEGINNING ON MAR 1, 2017.THE CO PLANS TO USE THE NET PROCEEDS FROM THE OFFERING OF THE NOTES (I) FOR ITS ANTICIPATED COST REDUCTION PROGRAM TO BE IMPLEMENTED DURING THE FIRST HALF OF 2017 ( 30-40 MLN), (II) FOR CAPEX ( 15-20 MLN), (III) TO REPURCHASE COMMON STOCK AS PART OF ITS STOCK REPURCHASE PROGRAM (UP TO 15 MLN) AND (IV) FOR GENERAL CORPORATE PURPOSES. 8:36 AM GAPPING DOWN ( SCANX ) : Gapping down In reaction to disappointing earningsguidance: NVDQ -17.3, (sees Q4 rev below consensus sees FY17 rev below consensus), SVU -8.1, SIG -4.6, BWA -1.9, LMNR -1.6 MampA news: ADM -5.6 (to acquire Crosswind Industries terms not disclosed) Select pharma related names showing weakness: BMY -3.6, AZN -1.6, SHPG -1.1 Other news: SGNL -12.8 (pulling back following recent strength)ETRM -11.2 (pulling back following recent strength)GNVC -7.4 (pulling back following recent strength)PTN -5.3 (Palatin Technologies to hold call following closing of licensing agreement with AMAG Pharmaceuticals for North American rights to Rekynda)PFGC -5 (prices 10 mln common stock offering by certain of its stockholders, including affiliates of The Blackstone Group ( BX ) at 22.85share )BRG -4.7 (commenced a public offering of 4,000,000 shares of its Class A common stock)TERP -4.5 (Brookfield Asset Management affirms 12.12 active stake, discloses the submission of alternative proposals to the companys advisors with respect to a potential transaction involving the company andor TerraForm Global)PE -2.9 (announces Midland Basin and Delaware Basin acquisitions and introduces 2017 capital program and operating gUIDANCE EXPECTS 60 ANNUAL PRODUCTION GROWTH IN 2017 COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF 20,000,000 SHARES OF CLASS A COMMON STOCK). Analyst comments: HIMX -2.5 (downgraded to Neutral from Buy at ROTH Capital)WUBA -1.6 (initiated with a Underperform at Bernstein)JD -1 (initiated with an Underperform at Bernstein )C -0.8 (downgraded to Sell at UBS)BIDU -0.7 (INITIATED WITH A UNDERPERFORM AT BERNSTEIN) 8:34 AM BROADCOM ANNOUNCES PRIVATE OFFERING OF SENIOR NOTES ( AVGO ). The notes will be guaranteed on a senior unsecured basis by Broadcom and certain of its other subsidiaries. The Co-Issuers intend to use the net proceeds from the sale of the notes to repay indebtedneSS OUTSTANDING UNDER BROADCOMS CREDIT FACILITY AND TO PAY RELATED FEES AND EXPENSES. 8:33 AM GULF RESOURCES ANNOUNCES THE COMPLETION OF ITS FIRST BRINE WATER AND NATURAL GAS WELL FIELD CONSTRUCTION IN SICHUAN PROVINCE EXPECT TO BE ABLE TO BEGIN TRIAL PRODUCTION IN THE VERY NEAR FUTURE ( GURE ). 8:32 am Rockwell Automation appoints VP investor relations and VP, finance, of the Architecture amp Software Patrick Goris as CFO effective Feb. 7 ( ROK ). 8:31 am Great Panther Silver announces Q4 production highlights co expects 2017 production level of 4.0-4.1 million Ag eq oz (at a 70:1 ratio) from its Mexico operations ( GPL ) : 2016 Production Highlights (COMPARED TO FULL YEAR 2015) CONSOLIDATED METAL PRODUCTION -7 TO 3,884,960 SILVER EQUIVALENT OUNCES SILVER PRODUCTION -14 TO 2,047,260 SILVER OUNCES GOLD PRODUCTION 2 TO 22,238 GOLD OUNCES ORE PROCESSED WAS STEADY AT 376,739 TONNES 4Q16 Production Highlights (Compared to Fourth Quarter 2015) Consolidated metal production decreased 12 to 883,772 Ag eq oz Silver production decreased 17 to 460,571 Ag oz Gold production decreased 8 to 5,206 Au oz Ore processed decreased 2, with 92,869 tonnes milled 8:30 am Ecolab acquires Abednego Environmental Services terms not disclosed ( ECL ). Abednego is a privately held company with 40 million in annual revenues that provides chemistry and service solutions to help automotive customers in their paint operations. 8:30 am SampP futures vs fair value: -2.00. Nasdaq futures vs fair value: -0.40. (:WRAPX) : The stock market is on track for a slightly lower open as the SampP 500 futures trade two points below fair value. The slow start to the day follows a notably quiet night of corporate news. Rite Aid (RAD 8.65, 0.33) is higher by 4.0 this morning on the heels of a New York Post report that the FTC could bE NEAR APPROVING THE COMPANYS PENDING SALE TO WALGREENS BOOT ALLIANCE (WBA 82.67, 0.00). CONVERSELY, SIGNET JEWELERS (SIG 83.25, -4.21) IS TICKING LOWER BY 4.8 AFTER LOWERING ITS Q4 EARNINGS AND COMPARABLE SALES GUIDANCE AMID DISAPPOINTING HOLIDAY RESULTS. U. S. TREASURIES HAVE SEEN A SLIGHT UPTICK IN BUYING INTEREST WITH THE 10-YR YIELD DOWN ONE BASIS POINT TO 2.37. ALSO OF NOTE, THE U. S. DOLLAR INDEX (102.44 0.43) IS HIGHER BY 0.4 AMID WEAKNESS IN BOTH THE EURO (1.0505) AND THE JAPANESE YEN (116.23). WHILE THERE ARE NO MAJOR ECONOMIC REPORTS TODAY, PRESIDENT-ELECT TRUMPS quotgeneral news conferencequot is likely to be analyzed by investors. Mr. Trump is scheduled to speak from the Trump Tower lobby at 11 am ET. 8:30 am Gapping up ( SCANX ) : Gapping up In reaction to strong earningsguidance: ICHR 9, (sees Q4 revs 131 MLN VS 117.90 MLN CAPITAL IQ CONSENSUS ESTIMATE, EXPECTS Q1 SALES TO BE HIGHER THAN Q4)MSM 2.5, DE 1.2, (LIGHT VOLUME RELEASES DECEMBER RETAIL SALES UPDATE)MX 0.8, (MAGNACHIP SEMI REPORTS PRELIM Q4 SALES AT HIGH END OF GUIDANCE ABOVE CONSENSUS ANNOUNCES PROPOSED 65 MLN PRIVATE OFFERING OF EXCHANGEABLE SENIOR NOTES AND STOCK REPURCHASE)VRX 0.5, (REITERATES FY16 GUIDANCE) MampA news: DSCI 41 (to be acquired by Integra LifeSciences ( IART ) for 7.00 per share)RAD 4 (NY Post discusses that regulators might complete review of Walgreens ( WBA ) and Rite Aide ( RAD ) merger before President Obama leaves office), Other news: BIOC 43.1 (continued strength)ENPH 22.1 (announces a 10 mln private placement of its common stock to T. J. Rodgers and John Doerr, chairman of Kleiner Perkins Caulfield amp Byers)TGTX 10 (completion of enrollment in part 1 of its phase II study of TG-1101)AKAO 9.3 (Baker Bros discloses 13.1 passive stake)SGMO 6.8 (granted orphan designation by the FDA for its compound for the treatment of mucopolysaccharidosis type I )CTSO 6.3 (light volume CytoSorbents and the U. S. Air Force determine to close the Company-sponsored, 30 patient, single site, randomized controlled human pilot study of the CytoSorb product to evaluate patients with severe trauma and rhabdomyolysis)ARLZ 4.2 (USPTO has issued patent covering Yosprala which will expire in late 2032 with possible patent term adjustment into early 2033)MRK 3.1 (receives FDA acceptance of supplemental biologics license application for Keytruda in combo with chemotherapy for first-line treatment of metastatic non-squamous non-small cell lung cancer)RDHL 2.9 (RHB-104 has been granted QIDP designation by the FDA for the treatment of Nontuberculous Mycobacteria infection)UAL 2.8 (expects Q416 consolidated passenger unit rev to decline 1.25-1.75 (prior 3-4) compared to Q416)GST 2.1 (declares special cash dividends on 8.625 Series A Preferred Stock and 10.75 Series B Preferred Stock enters into related amendment of credit agreement)AAL 1.6 (reports December traffic, raises Q4 TRASM, pre-tax margin RPMs -0.8 yy)MYL 1 (FDA has accepted Mylans biologics license application for MYL-1401O, a proposed biosimilar trastuzumab) Analyst comments: KERX 4.8 (upgraded to Neutral from Sell at Citigroup)BT 2.7 (upgraded to Overweight from Equal Weight at Morgan Stanley)ESV 1.7 (upgraded to Buy from Neutral at Citigroup)WRD 1.7 (initiated with a Strong Buy at Raymond James)PANW 0.8 (initiated with Outperform ratings at Wells Fargo) 8:29 am On The Wires (:WIRES). IBM Watson Health (IBM) has signed a research initiative with the FDA aimed at defining a secure, efficient and scalable exchange of health data using blockchain technology. IBM and the FDA will explore the exchange of owner mediated data from several sources, such as Electronic Medical Records, clinical trials, genomic data, and health data from mobile devices, wearables and the quotInternet of Things. quot The initial focus will be on oncology-related data. Bird Rock Bio announced that it has received approval for the initiation of a two-part Phase 1 clinical trial for namacizumab, a novel therapeutic antibody to the cannabinoid 1 receptor. In addition, Bird Rock Bio has entered into an agreement with GE Healthcare (GE) for process development, formulation, and manufacture of namacizumab in preparation for Phase 2 studies. Furthermore, the Phase 1 trial, process development, and Phase 2 preparation will be funded under a collaboration and option agreement with Janssen Pharmaceuticals (JNJ). The J. M. Smucker Company (SJM) announced an increase in the list price for the majority of its packaged coffee products sold in the United States, primarily consisting of items sold under the Folgers, Dunkin Donuts, and Caf Bustelo brand names. Prices increased an average of six percent on impacted items in response to sustained increases in green coffee costs. The Companys K-Cup pods were excluded from the price increase. Subsidiaries of Imperial Brands PLC (IMBBY) and China Tobacco have established a dynamic long-term Joint Venture business which will LOOK TO DEVELOP A VARIETY OF GROWTH OPPORTUNITIES IN CHINA AND INTERNATIONAL MARKETS. GLOBAL HORIZON VENTURES LIMITED IS INITIALLY FOCUSED ON: LEVERAGING THE EXPERTISE OF CHINAS LARGEST TOBACCO COMPANY, YUNNAN TOBACCO, TO DRIVE THE SUSTAINABLE GROWTH OF IMPERIALS GROWTH BRANDS WEST AND DAVIDOFF IN CHINA AND MAXIMISING THE POTENTIAL OF TWO YUNNAN BRANDS, JAD AND HORIZON, IN MARKETS OUTSIDE OF CHINA. AT ITS BOARD MEETING, SNCF SELECTED THE ALSTOM (ALSMY)-BOMBARDIER (BDBRF) CONSORTIUM TO RENEW THE TRAINS ON LINES D AND E OF THE LE-DE-FRANCE NETWORK. THIS CONTRACT FOR 255 TRAINS (130 FOR THE RER D AND 125 FOR THE RER E), WORTH AN ESTIMATED 3.75 BILLION EUROS, IS THE LARGEST CONTRACT EVER FINANCED BY STIF. 8:05 AM TAKEDA PHARMA INVESTS 125 MLN IN MAVERICK THERAPEUTICS, INCLUDING OPTION-TO-ACQUIRE ( TKPYY ) : Cos entered a collaboration to develop Mavericks T-cell engagement platform created specifically to improve the utility of T-cell redirection therapy for the treatment of cancer. The 125 million of funding includes an upfront option, equity and RampD funding payments, and provides Takeda the exclusive right to purchase Maverick after five years for an undisclosed sum. 8:03 am SampP futures vs fair value: -1.80. Nasdaq futures vs fair value: 0.10. (:WRAPX) : Equity futures point to a slightly lower open on Wednesday morning as the SampP 500 futures trade two points below fair value. Global markets are mixed with Asia closing on a mostly higher note while European indices hover near their flat lines. Crude oil is up for the first time in three days amid reports that Saudi Arabia, the worlds top exporter, plans to cut supply to Asia. The commodity is higher by 0.4, trading at 51.03bbl. U. S. Treasuries are flat this morning amid an uptick in the U. S. dollar. The 10-yr yield remains unchanged at 2.38, while the U. S. Dollar Index (102.39, 0.38) is up 0.4. Todays only economic data was the MBA Mortgage Index, which crossed the wires at 7:00 am ET this morning. The index came in at 5.8. In U. S. corporate news of note: Tesla Motors (TSLA 229.00, -0.87): -0.4 after the company named Apple (AAPL 118.75, -0.36) engineer Chris Lattner vice president of autopilot software. Ford Motor (F 12.72, -0.13): -1.0 despite reaffirming positive guidance for 2017.Citigroup (C 59.80, -0.43): -0.7 after the stock was downgraded to Sell at UBS. Reviewing overnight developments: Markets in the Asia-Pacific region ended Wednesday on a mixed note, but the trading day was fairly quiet. Japans Nikkei 0.3, Hong Kongs Hang Seng 0.8, Chinas Shanghai Composite -0.8, Indias Sensex 0.9.In economic data: Japans November Leading Index 102.7 (expected 102.6 previous 100.8). November Coincident Indicator 1.6 month-over-month (last 1.0) South Koreas December Unemployment Rate declined to 3.4 from 3.6. December Import Price Index 9.2 year-over-year (last 3.6) and December Export Price Index 6.3 year-over-year (last 3.5)In news:The World Bank lowered its GDP growth outlook for 2017 and 2018, but the adjustment only reduced the previous forecast by 10 basis points. The forecast for 2017 was lowered to 2.7 from 2.8. The U. S. growth forecast for 2017 was maintained at 2.2 due to the expected impact of fiscal stimulus under the new administration. Major European indices trade near their flat lines with Germanys DAX showing relative strength while Italys MIB underperforms. Germanys DAX 0.2, Frances CAC unch, UKs FTSE unch, Italys MIB -0.4.In economic data:UKs November Industrial Production 2.1 month-over-month (expected 0.8 last -1.1) 2.0 year-over-year (consensus 0.6 previous -0.9). November Manufacturing Production 1.3 month-over-month (expected 0.5 last -1.0) 1.2 year-over-year (consensus 0.4 last -0.5). November Construction Output -0.2 month-over-month (expected 0.3 last -0.6) 1.5 year-over-year (consensus 2.0 previous 0.7). November trade deficit widened to GBP12.16 billion from GBP9.89 billion (expected deficit of GBP11.20 billion) SpaiNS NOVEMBER INDUSTRIAL PRODUCTION 3.2 YEAR-OVER-YEAR (CONSENSUS 1.0 LAST 0.6)IN NEWS:ALTHOUGH EQUITY MARKETS HAVE MAINTAINED NARROW RANGES SO FAR, THE EURO HAS RETREATED STEADILY, FALLING 0.4 AGAINST THE DOLLAR TO 1.0514. THE DECLINE LEAVES THE SINGLE CURRENCY IN THE BOTTOM HALF OF ITS TRADING RANGE THAT DATES BACK TO EARLY DECEMBER. THE BRITISH POUND HAS ALSO RETREATED AGAINST THE DOLLAR, SURRENDERING 0.5 TO 1.2121, DESPITE ABOVE-CONSENSUS ECONOMIC DATA. ON BALANCE, ECONOMIC DATA RECEIVED SINCE THE BREXIT VOTE HAS BEEN STRONG RELATIVE TO EXPECTATIONS. 8:02 AM REDHILL BIOPHARMA ANNOUNCES THAT RHB-104 HAS BEEN GRANTED QIDP DESIGNATION BY THE FDA FOR THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIA INFECTIONS CO WILL CONSULT WITH THE FDA REGARDING ITS RHB-104 DEVELOPMENT PROGRAM FOR NTM INFECTIONS ( RDHL ). The granted QIDP designation allows RedHill to benefit from Fast-Track status, with an expedited development pathway for RHB-104 for the treatment of NTM infections, as well as Priority Review, which provides for a shorter review time by the FDA of a future potential marketing application. If approved for the treatment of NTM infections, RHB-104 would also receive an additional five years of U. S. market exclusivity on top of the standard exclusivity period. In light of the QIDP designation, RedHill will consult with the FDA regarding its RHB-104 development program for NTM infections. Under FDAs Generating Antibiotic Incentives Now Act, QIDP designation allows for Fast-Track status and PriORITY REVIEW, POTENTIALLY LEADING TO A SHORTER NDA REVIEW TIME BY THE FDA, AND, IF APPROVED, AN ADDITIONAL FIVE YEARS OF U. S. MARKET EXCLUSIVITY ON TOP OF THE STANDARD EXCLUSIVITY PERIOD. A FIRST PHASE III CLINICAL STUDY WITH RHB-104 FOR THE TREATMENT OF CROHNS DISEASE (THE MAP US STUDY) IS ONGOING IN THE U. S. AND ADDITIONAL COUNTRIES INCREASING EVIDENCE SUPPORTS THE HYPOTHESIS THAT CROHNS DISEASE, AND POTENTIALLY OTHER AUTOIMMUNE DISEASES, ARE RELATED TO MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS (:MAP) INFECTION IN SUSCEPTIBLE PATIENTS. TOP-LINE FINAL RESULTS FROM THE CEASE MS STUDY SUGGEST MEANINGFUL POSITIVE SAFETY AND CLINICAL SIGNALS UPON 24 WEEKS OF TREATMENT WITH RHB-104 AS AN ADD-ON THERAPY, THEREBY SUPPORTING FURTHER CLINICAL DEVELOPMENT. 8:02 AM AMERICAN AIRLINES REPORTS DECEMBER TRAFFIC, RAISES Q4 TRASM, PRE-TAX MARGIN RPMS -0.8 YY ( AAL ) : American Airlines Groups total revenue passenger miles (RPMs) were 18.2 billion, down 0.8 percent versus December 2015. Total capacity was 22.6 billion available seat miles (ASMs), up 0.5 percent versus December 2015. Total passenger load factor was 80.6 percent, down 1.0 percentage point versus December 2015. Co expects Q4 total revenue per available seat mile (:TRASM) to be flat to up 2 (Prior guidance: -1 to 1). In addition, the Company expects its fourth quarter pre-tax margin excluding special items to be 7-9 (Prior guidacne: 6-8) 8:02 am Vivint Solar closes new financing in two separate transactions a 203 mln debt facility and a 100 mln follow-on investment in tax equity financing ( VSLR ). Co closed a FIXED-RATE, 18-YEAR TERM DEBT FACILITY WITH FOUR INSTITUTIONAL INVESTORS, TOTALING 203 MILLION. THE NEW DEBT FACILITY IS A FULLY AMORTIZING LOAN THAT RELIES ON THE CONTRACTUAL CASH FLOWS FROM FOUR EXISTING INVESTMENT FUNDS THAT COMPRISE APPROXIMATELY 214 MEGAWATTS (MWS) AND 30,000 RESIDENTIAL SOLAR SYSTEMS. IN ADDITION, THE COMPANY ALSO ANNOUNCED TODAY THAT IT CLOSED AN INVESTMENT WITH BANK OF AMERICA MERRILL LYNCH, AN EXISTING INVESTOR THAT HAD COMMITTED A 100 MILLION FOLLOW-ON INVESTMENT IN TAX EQUITY FINANCING, WHICH WILL ALLOW THE INSTALLATION OF OVER 66 MWS OF RESIDENTIAL SOLAR ENERGY SYSTEMS. THIS INVESTMENT MARKS THE CLOSING OF A PORTION OF THE TAX EQUITY COMMITMENTS VIVINT SOLAR RECEIVED IN NOVEMBER 2016. 8:01 AM SANDSTORM GOLD ANNOUNCES CO SOLD OVER 13,200 ATTRIBUTABLE GOLD EQUIVALENT OZ DURING THE FOURTH QUARTER OF 2016 amp OVER 49,500 GOLD EQUIVALENT OUNCES FOR THE FULL 2016 YEAR ( SAND ). Co announce that the Company has sold over 13,200 attributable gold equivalent ounces1 during the fourth quarter of 2016 and over 49,500 gold equivalent ounces for the full 2016 year. Both the fourth quarter and annual production results are records for the Company. The attributable gold equivalent ounces were generated from 21 streams and royalties, with over 70 of the ounces coming from operations run by major and mid-tier mining companies. 8:01 am Mylan N. V. announces that the FDA has accepted Mylans biologics license application for MYL-1401O, a proposed biosimilar trastuzumab ( MYL ). Co announces that the FDA has accepted Mylans biologics license application for MYL-1401O, a proposed biosimilar trastuzumab, for filinG THROUGH THE 351 PATHWAY. THIS PRODUCT IS A PROPOSED BIOSIMILAR TO BRANDED TRASTUZUMAB, WHICH IS INDICATED TO TREAT CERTAIN HER2-POSITIVE BREAST CANCERS. THE ANTICIPATED FDA GOAL DATE SET UNDER THE BIOSIMILAR USER FEE ACT IS SEPT. 3, 2017. 8:00 AM ON THE WIRES (:WIRES). AMAZON (AMZN) AND CHASE (JPM) INTRODUCED THE NEW AMAZON PRIME REWARDS VISA SIGNATURE CARD, THE ONLY CARD THAT OFFERS 5 BACK ON ALL AMAZON PURCHASES AND REWARDS EVERYWHERE ELSE YOU SHOP, INCLUDING 2 BACK AT RESTAURANTS, GAS STATIONS AND DRUGSTORES, AND 1 BACK ON EVERY OTHER PURCHASE, AVAILABLE EXCLUSIVELY FOR ELIGIBLE PRIME MEMBERS. VIACOM INC. (VIAB) ANNOUNCED THE APPOINTMENT OF DAVID LYNN AS PRESIDENT AND CEO OF VIACOM INTERNATIONAL MEDIA NETWORKS (:VIMN). 7:46 AM KORNIT DIGITAL TO DELIVER A LARGE NUMBER OF TEXTILE PRODUCTION SYSTEMS TO AMAZON ( AMZN ) in support of its Merch by Amazon program co to grant Amazon warrants to acquire over a five-year period up to 2,932,176 of its common shares at 13.03share ( KRNT ) : Through this agreEMENT, KORNIT WILL DELIVER THE COMPANYS FLAGSHIP HIGH-PRODUCTIVITY SYSTEM, THE AVALANCHE 1000, TO SUPPORT AMAZONS EXPANSION OF PRODUCTION CAPACITY FOR THE COMPANYS MERCH BY AMAZON SERVICE. IN CONJUNCTION WITH THE COMMERCIAL AGREEMENTS, KORNIT DIGITAL HAS AGREED TO GRANT AMAZON WARRANTS TO ACQUIRE OVER A FIVE-YEAR PERIOD UP TO 2,932,176 OF KORNIT DIGITALS COMMON SHARES AT 13.03SHARE, BASED ON THE VOLUME WEIGHTED AVERAGE CLOSING PRICES OF KORNIT DIGITAL COMMON SHARES FOR THE THIRTY TRADING DAYS PRIOR TO JANUARY 10, 2017. 7:31 AM STELLAR BIOTECHNOLOGIES TO EXPAND PRODUCTION OF ITS STELLAR KLH PRODUCTS UNDER A RECENTLY ESTABLISHED MEXICAN SUBSIDIARY ( SBOT ). 7:31 am TG Therapeutics announces completion of enrollment in part 1 of its phase II study of TG-1101 early data demonstrates rapid and profound B-cell reductions in MS patients treated with TG-1101 with median B-cell reduction of 99 ( TGTX ) : TG-1101 is a novel glycoengineered anti-CD20 monoclonal antibody in patients with relapsing forms of multiple sclerosis. Phase 3 MS program planned to initiate in 1H 2017. The primary objective of the study was to assess the safety and tolerability of TG-1101 in patients with RMS as well as to determine the optimal dosing regimen for TG-1101 by examining the level of B-cell depletion and the tolerability of accelerated infusion times. Established MS clinical efficacy endpoints are also being evaluated, which require longer-term follow-up and are anticipated to be reported on later this year or next year at a medical conference. The median B-celL DEPLETION FOR ALL PATIENTS IN PART 1 WAS 99 AND TG-1101 WAS WELL-TOLERATED WITH NO GRADE 34 ADVERSE EVENTS REPORTED, INCLUDING IN PATIENTS RECEIVING THE ONE-HOUR INFUSION AT THE TARGET PHASE 3 DOSE AND INFUSION RATE. AS PART 2 OF THE TRIAL, THE COMPANY HAS ADDED EXPANSION COHORTS AND WILL EXPLORE ACCELERATED DOSING OF THE INITIAL 150MG DOSE. quotThe speed at which we were able to rapidly enroll into this study demonstrates the on-going need for new treatment options for patients. We were extremely pleased to see rapid and robust B-cell depletion and excited to see that a one-hour infusion was well tolerated, possibly providing an important convenience advantage over first generation anti-CD20 monoclonal antibodies. We look forward to continuing enrollment into one or more expansion cohorts and to launching a Phase 3 program in the first half of this year. quot 7:30 am Sangamo BioSci confirms that the FDA has granted orphan drug designation to SB-318 for the treatment of Mucopolysaccharidosis Type I ( SGMO ). MPS I is caused by mutations in the gene encoding the alpha-L-iduronidase (:IDUA) enzyme. Using Sangamos zinc finger nuclease (:ZFN) genome editing technology, SB-318 is designed as a single treatment strategy intended to provide stable, continuous production of the IDUA enzyme for the lifetime of the patient. In 2017, Sangamo plans to conduct the first ever in vivo genome editing clinical trials including Phase 12 studies for three lead programs: SB-318 for the treatment of MPS I SB-913 for the treatment of MPS II, another rare lysosomal storage disorder and SB-FIX for the treatment of hemophilia B, a rare blood disease. Data from these studies and from a planned clinical trial for a fourth lead program, SB-525, a gene therapy approach for hemophilia A, are expected in late 2017 or early 2018. 7:29 am On The Wires (:WIRES). Attunity Ltd. (ATTU) announced today that a global, multi-billion dollar insurance company has signed an agreement for 0.8 million in license fees, services and five years of maintenance for Attunity Replicate, which is expected to significantly enhance the performance of the Customers recently implemented data lake analytics solution. Kratos Defense amp Security Solutions (KTOS) announced today that Digital Fusion Solutions, a subsidiary of Kratos Defense amp Rocket Support Services Division, is increasing its support of high energy laser demonstrator development through a task order under its U. S. Army Space and Missile Defense CommandArmy Forces Strategic Command Integrated Test and Analysis Contract Prime Contract. The task is to assist SMDC with High Energy Laser System Engineering, Integration, and Test Support. Kratos support has expanded to include integration and test support at their high bay facility in Huntsville, AL. 7:23 am European Markets Update: DAX 0.4, CAC 0.1, FTSE 0.1 (:SUMRX) : Major European indices trade near their flat lines with Germanys DAX (0.4) showing relative strength while Italys MIB (-0.3) underperforms. Although equity markets have maintained narrow ranges so far, the euro has retreated steadily, falling 0.5 against the dollar to 1.0508. The decline leaves the single currency in the bottom half of its trading range that dates back to early December. The British pound has also retreated against the dollar, surrendering 0.5 to 1.2121, despite above-consensus economic data. On balance, economic data received since the Brexit vote has been strong relative to expectations. In economic data: UKs November Industrial Production 2.1 month-over-month (expected 0.8 last -1.1) 2.0 year-over-year (consensus 0.6 previous -0.9). November Manufacturing Production 1.3 month-over-month (expected 0.5 last -1.0) 1.2 year-over-year (consensus 0.4 last -0.5). November Construction Output -0.2 month-over-month (expected 0.3 last -0.6) 1.5 year-over-year (consensus 2.0 previous 0.7). November trade deficit widened to GBP12.16 billion from GBP9.89 billion (expected deficit of GBP11.20 billion) Spains November Industrial Production 3.2 year-over-year (consensus 1.0 last 0.6) ---Equity Markets--- Germanys DAX is higher by 0.4 with heavyweights Volkswagen, Deutsche Bank, Daimler, and Merck among the leaders. The four namES ARE UP BETWEEN 1.0 AND 3.7. ON THE DOWNSIDE, SIEMENS AND BMW ARE DOWN 1.0 AND 0.2, RESPECTIVELY. FRANCES CAC HAS ADDED 0.1 AMID RELATIVE STRENGTH IN AUTOMAKERS. PEUGEOT AND RENAULT HOLD RESPECTIVE GAINS OF 3.1 AND 1.0 WHILE MICHELIN HAS ADDED 1.1. FINANCIALS TRADE IN THE RED WITH BNP PARIBAS, SOCIETE GENERALE, AND CREDIT AGRICOLE DOWN BETWEEN 0.4 AND 0.7. UKS FTSE IS HIGHER BY 0.1 THANKS TO GAINS IN CONSUMER NAMES. DIXONS CARPHONE, SAINSBURY, MARKS amp SPENCER, AND UNILEVER SHOW GAINS BETWEEN 0.4 AND 3.6. SELECT FINANCIALS LAG WITH RBS, BARCLAYS, STANDARD LIFE, AND RSA INSURANCE DOWN BETWEEN 1.0 AND 1.8. ITALYS MIB HAS SHED 0.3. FINANCIALS LIKE BANCO BPM, BANCA POP EMILIA ROMAGNA, UNICREDIT, MEDIOBANCA, INTESA SANPAOLO, AND UBI BANCA ARE DOWN BETWEEN 0.6 AND 2.7. 7:17 AM GLAXOSMITHKLINE EXPECTS THAT THE POSITIVE IMPACT OF FOREIGN EXCHANGE ON FULL YEAR 2016 STERLING CORE EPS WILL BE GREATER THAN THE POSITIVE IMPACT ON SALES ( GSK ). quotAs a result of the mix of currency movements relative to the mix of costs, we expect that the positive impact of foreign exchange on full year 2016 sterling core EPS will be greater than the positive impact on sales. quotquotOver the first nine months of 2016, the benefit of currencies to core EPS was 20 compared with the 8 benefit to sales. quotGSK expects to pay an annual ordinary dividend of 80p for each of the next two years (2016-2017).quotquotIn Respiratory, we continued to transition the portfolio from its previous reliance on AdvairSeretide to a much broader one. Total Respiratory sales were up 8 globally, with double digit growth in the US and International, more than offsetting a 9 decline in Europe. This is primarily the result of growth in the new Ellipta products and Nucala, up 179 million in Sterling terms, which more than offset the 7 decline in AdvairSeretide, which slowed its rate of decline in the quarter. This primarily reflected a mix in the period of better RAR in the US and an improved performance in the emerging markets, offset by continued competitive pressures in Europe. quot 7:02 am Asian Markets Close: Nikkei 0.3, Hang Seng 0.8, Shanghai -0.8 (:SUMRX) : Markets in the Asia-Pacific region ended Wednesday on a mixed note, but the trading day was fairly quiet. The World Bank did lower its GDP growth outlook for 2017 and 2018, but the adjustment only reduced the previous forecast by 10 basis points. The forecast for 2017 was lowered to 2.7 from 2.8. The U. S. growth forecast for 2017 was maintained at 2.2 due to the expected impact of fiscal stimulus under the new administration. In economic data: Japans November Leading Index 102.7 (expected 102.6 previous 100.8). November Coincident Indicator 1.6 month-over-month (last 1.0) South Koreas December Unemployment Rate declined to 3.4 from 3.6. December Import Price Index 9.2 year-over-year (last 3.6) and December Export Price Index 6.3 year-over-year (last 3.5) ---Equity Markets--- Japans Nikkei added 0.3. Growth-sensitive names like SUMCO, Nippon Sheet Glass, Kobe Steel, Sumitomo Metal Mining, Japan Steel Works, Mitsubishi Materials, and Ebara posted gains between 2.0 and 4.4. Hong Kongs Hang SenG CLIMBED 0.8 AMID STRENGTH IN PROPERTY NAMES AND FINANCIALS. SINO LAND, NEW WORLD DEVELOPMENT, HANG LUNG PROPERTIES, CHEUNG KONG PROPERTY HOLDINGS, CHINA OVERSEAS, BANK OF CHINA, PING AN INSURANCE, AND HSBC ADDED BETWEEN 0.8 AND 3.8. CHINA UNICOM HONG KONG LAGGED FOR THE SECOND DAY IN A ROW, FALLING 2.0. CHINAS SHANGHAI COMPOSITE LOST 0.8. SHANG GONG GROUP, TIANJIN GLOBAL MAGNETIC CARD, WUHAN HANSHANG, AND SHEN MA INDUSTRY REGISTERED LOSSES BETWEEN 5.4 AND 6.8. INDIAS SENSEX ADDED 0.9 WITH HELP FROM MOST COMPONENTS. COAL INDIA SPIKED 5.4 WHILE OTHER GROWTH-SENSITIVE NAMES LIKE TATA STEEL, LARSEN amp TOUBRO, POWER GRID, AND MAHINDRAampMAHINDRA RALLIED BETWEEN 1.3 AND 4.0. BAJAJ AUTO WAS THE WEAKEST PERFORMER, FALLING 0.9. ---FX--- USDJPY 0.4 TO 116.24 USDCNY 0.2 TO 6.9341 USDINR UNCH AT 68.350 7:02 AM FORTUNA SILVER MINES ANNOUNCES FY16 TOTAL PRODUCTION OF 7.4 MLN OZ OF SILVER amp 46.6 K OZ OF GOLD ISSUES GUIDANCE FOR FY17 ( FSM ). FY16 PRODUCTION HIGHLIGHTS:SILVER AND GOLD PRODUCTION WERE 5 AND 9 RESPECTIVELY ABOVE 2016 GUIDANCE. SILVER PRODUCTION OF 7,380,217 OUNCES 11 INCREASE OVER 2015.GOLD PRODUCTION OF 46,551 OZ 17 INCREASE OVER 2015.ZINC PRODUCTION OF 43,204,154 POUNDS 21 INCREASE OVER 2015.LEAD PRODUCTION OF 32,673,479 POUNDS 37 INCREASE OVER 2015.quotIn 2017, our expansion plans are going to be underpinned by our solid low-cost production base providing financial flexibility to execute engineering and development plans for Lindero and continue exploring for new compelling precious metal opportunities in the Americas and abroad. quotFY17 guidance:2017 silver equivalent production guidance of 11.2 mln oz.2017 consolidated AISC of 9.8oz Ag. 7:01 am Asanko Gold announces production results for the fourth quarter of 2016 gold production of 57,178oz and gold sales of 58,483oz against production guidance of 52,000 - 57,000oz ( AKG ) : Commenting on the quarters performance, Peter Breese, President and CEO, said, quotThe operations once again had an impressive quaRTER WITH RECORD PRODUCTION OF OVER 57,000 OUNCES. WITH THE MINE NOW DELIVERING AGAINST EXPECTATIONS AND THE PROCESS PLANT RUNNING STEADILY AT 300,000 TONNES PER MONTH, OR ABOUT 20 ABOVE DESIGN, WE ENTER 2017 WITH A HIGH PERFORMANCE OPERATING ASSET THAT WILL POSITION US WELL TO FINANCE OUR PHASE 2A EXPANSION PROJECT WITH CASH FLOW FROM THE OPERATIONS. quot Gold production of 57,178oz and gold sales of 58,483oz against production guidance of 52,000 - 57,000ozUS70.1m in gold revenue at an average realized price of US1,199 per ounce 901,000 tonnes processed during the quarter with a feed grade of 2.15gtIndustry-leading safety record maintained with no LTIs reported during the quarter and a rolling 12 month LTIFR of 0.20. Strong balance sheet with unaudited cash and immediately convertible working capital balances of approximately US66 million (December 31, 2016) 7:01 am Performance Food Group prices 10 mln common stock offering by certain of its stockholders, including affiliates of The Blackstone Group ( BX ) at 22.85share ( PFGC ). 7:01 am Ethan Allen issues downside prelim Q2 results, written retail orders -3.6 ( ETH ) : Co sees Q2 EPS of 0.38-0.39 vs 0.59 Capital IQ Consensus Estimate revs 194.7 mln vs 213.67 mln Capital IQ Consensus Estimate. quotDespite a challenging retail environment during our second quarter ending December 31, 2016 we had a reduction of 3.6 percent in our written retail orders compared to a record written increase of 15.3 percent in the previous year quarter. Due to a delivered sales decline of 6.2 percent, our adjusted operating income is projected to bE APPROXIMATELY 8.8 PERCENT OF SALES COMPARED TO 12.2 PERCENT OF SALES IN THE PREVIOUS YEAR QUARTER. OUR ADJUSTED EARNINGS PER SHARE IS PROJECTED TO BE 0.38- 0.39 COMPARED TO 0.55 IN THE PREVIOUS YEAR SECOND QUARTER. quot quotWe are positioned well to benefit from many initiatives including freshening of our offerings, launch of the Ethan AllenDisney collaboration, improvements to our manufacturing and logistics resulting in faster deliveries, relocations and renovations of our design centers, and investments in technology. We are seeing increases in sales from on-line interactions and we expect to see continued increases due to the combination of technology and personal services of our interior designers. Our plans are to start substantially increasing our marketing in both digital and traditional mediums starting from our current third quarter with continued increases as we move forward. quot 7:01 am Upland Software acquires Omtool for 19.2 million (net of cash acquired), expects total revenue and Adjusted EBITDA for the quarter ended December 31, 2016 to be at the upper end of previously-announced guidance ranges. ( UPLD ) : quotQ4 came in strong with continued success in expanding our customer relationships allowing us to affirm our healthy Q4 outlook and to provide record Q1 guidance that reflects both the Omtool acquisition and the continued growth in our core business, quot said Mr. McDonald. quotFinally, we are raising our long term Adjusted EBITDA margin target to 35 to reflect the increased customer loyalty and operating efficiency we are seeing as we scale. quot The purchase price paid for Omtool was 19.2 million (net of cash acquired), within Uplands target range of 5-8x pro forma Adjusted EBITDA. Upland expects the acquisition to generate approximately 11 million in revenue in 2017, subject to reductions for a deferred revenue discount as a result of GAAP purchase accounting. The transaction will be immediately accretive to Uplands Adjusted EBITDA per share. In addition, for the quarter ending March 31, 2017, Upland expects reported total revenue to be in the range of 20.0-20.8 mln including recurring revenue in the range of 17.5 million to 18.1 million vs. the 19.09 mln Capital IQ Consensus. Adjusted EBITDA is expected to be in the range of 5.0 million to 5.5 million, for an Adjusted EBITDA margin of 26 at the mid-point, representing growth of 162 at the mid-point over the quarter ended March 31, 2016.Upland raised its long term Adjusted EBITDA margin target from 30 to 35. 6:59 am On The Wires (:WIRES). Albemarle Corporation (ALB) announced that it intends to redeem all of its outstanding 3.000 Senior Notes due 2019 (CUSIP No. 012725AB3, ISIN No. US012725AB30) issued by it on February 10, 2017. The Notes will be redeemed at a redemption price equal to the greater of (1) 100 of the principal amount of the Notes and (2) the sum of the present values of the remaining scheduled payments of principal and interest on the Notes from the Redemption Date through the Par Call Date, as defined in the Notes, in each case discounted to the date of redemption on a semi-annual basis at the Treasury Rate plus 25 basis points, plus in each case, accrued and unpaid interest on the Notes redeemed to, but not including, the Redemption Date. CyTODYN INC. (CYDY) ANNOUNCED THE COMPANY FILED A REQUEST FOR BREAKTHROUGH THERAPY DESIGNATION WITH THE FDA FOR PRO 140 AS A TREATMENT FOR HIV-1 INFECTION IN TREATMENT-EXPERIENCED PATIENTS WITH VIROLOGIC FAILURE. BASED ON RESULTS FROM FOUR COMPLETED AND ONGOING CLINICAL TRIALS, THE COMPANY BELIEVES THE PRO 140 TREATMENT OPTION ADDRESSES THE UNMET MEDICAL NEED FOR THERAPY OPTIONS FOR HIV-1 INFECTED PATIENTS WITH UNCONTROLLED VIRAL LOAD, DESPITE CONVENTIONAL ANTIRETROVIRAL THERAPY. WEX (WEX) ANNOUNCED THAT IT HAS SIGNED A NEW AGREEMENT WITH ENTERPRISE FLEET MANAGEMENT IN CANADA. THE PARTNERSHIP SUPPORTS ENTERPRISES GROWTH IN THE CANADIAN MARKET THROUGH WEXS CANADIAN FLEET CAPABILITIES. B COMMUNICATIONS LTD. (BCOM) ANNOUNCED A PRIVATE PLACEMENT OF NIS 118,000,000 PAR VALUE OF ITS SERIES C DEBENTURES TO ISRAELI INSTITUTIONAL INVESTORS FOR AN AGGREGATE CONSIDERATION OF APPROXIMATELY NIS 118 MILLION (APPROXIMATELY US 31 MILLION). 6:58 AM GOLDEN STAR RESOURCES REPORTS Q4 GOLD PRODUCTION OF 53,403 OUNCES GUIDES FOR FY 17 GOLD PRODUCTION OF 255K-280K OZ. 31-44 YY ( GSS ). Gold production of 194,054 ounces in 2016, in the top half of the guidance range of 180,000 to 205,000 ounces Gold production by asset in 2016, as follows: Wassa Main Pit: 93,319 ounces Wassa Underground Gold Mine: 11,062 ounces Prestea Open Pits: 89,673 ouncesWassa Undergrounds mining rates accelerated strongly during the quarter, culminating in the declaration of commercial production on January 1, 2017 Cash and cash equivalents balance of 21.7 million as of December 31, 2016, which does not include the receipt of the 10 million scheduled advance payment on January 3, 2017 from RGLD Gold FY 17 guidance of: 255,000-280,000 ounces of gold production 780-860 per ounce cash operating cost1 970-1,070 per ounce All-In Sustaining Cost 6:56 am TherapeuticsMD announces the publication of 2 manuscripts detailing results of thE PHASE 3 REJOICE TRIAL IN MENOPAUSE: THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY ( TXMD ) : The Rejoice Trial is the pivotal phase 3 study of TX-004HR, an investigational bio-identical 17-estradiol vaginal softgel capsule, for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar vaginal atrophy (:VVA) in postmenopausal women. The manuscripts review the positive results of TX-004HR across all pre-specified primary and secondary endpoints in the Rejoice Trial, as well as data from a pharmacokinetic substudy demonstrating the low systemic absorption of TX-004HR. The FDA has set a Prescription Drug User Fee Act target action date of May 7, 2017 to complete its review of the companys 505(b)(2) NDA submission for TX-004HR. The NDA is supported by the complete TX-004HR clinical program, including positive results of the phase 3 Rejoice Trial, which evaluated the effect of three doses of TX-004HR (4 mcg, 10 mcg and 25 mcg) compared to placebo from baseline to week 12. 6:56 am Signet Jewelers lowers Q4 guidance holiday comps fell 4.6 ( SIG ). Lowers Q4 adj. EPS to 4.00-4.05 from 4.00-4.20 vs 4.05 Capital IQ Consensus lowers Q4 comps to (4.3-4.8) from (2-4). Nine week holiday comps fell 4.6 vs. 5.1 last year. Merchandise categories and collections were broadly lower most notably in the mall and e-commerce selling channels, while select merchandise and other selling channels performed relatively well such as diamond fashion jewelry, bracelets, earrings, Ever Us, Vera Wang Love, and the off-mall AND KIOSK SELLING CHANNELS. SIGNETS E-COMMERCE SALES IN THE HOLIDAY SEASON WERE 142.5 MILLION, DOWN 3.5 MILLION OR 2.4 COMPARED TO 146.0 MILLION IN THE PRIOR YEAR. quotSignets disappointing holiday results were driven principally by underperformance in its SterliNG DIVISION E-COMMERCE BUSINESS. A PRELIMINARY VIEW OF MARKET DATA SUGGESTS THAT THE JEWELRY CATEGORY WAS BROADLY FLAT TO MODESTLY DOWN WITH IN-STORE SALES DOWN MID-SINGLE-DIGITS AND E-COMMERCE SALES UP DOUBLE-DIGITS. SIGNETS IN-STORE RESULTS WERE IN-LINE WITH THE JEWELRY MARKET, BUT TECHNICAL PERFORMANCE ISSUES IN STERLINGS E-COMMERCE PLATFORM LARGELY LED TO SIGNETS LOWER-THAN-EXPECTED RESULTS. STERLINGS CHALLENGES IN ITS E-COMMERCE PLATFORM WERE DUE TO RECENT ENHANCEMENTS THAT DID NOT PERFORM AS EXPECTED WHEN EXPOSED TO HIGH HOLIDAY VOLUME. WE ARE INVESTING AND DIRECTING MORE RESOURCES TO IMPROVE THE FUNCTIONING OF THE PLATFORM AND THE OVERALL CUSTOMER DIGITAL JOURNEY. quotSelect categories, collections, and other selling channels performed relatively well. quot 6:53 am Gilead Sciences announces the EC has granted marketing authorization for Vemlidy for the treatment of chronic hepatitis B virus infection ( GILD ). The marketing authorization allows for the marketing of TAF in the 28 countries of the European Union, Norway, and Iceland. 6:50 am MSC Industrial beats by 0.02, reports revs in-line guides Q2 EPS above consensus, revs in-line ( MSM ). Reports Q1 (Nov) earnings of 0.95 per share, 0.02 better than the Capital IQ Consensus of 0.93 revenues fell 2.9 yearyear to 686.3 mln vs the 685.46 mln Capital IQ Consensus. GroSS MARGIN OF 45.0 REFLECTS CONTINUED STABILIZATION IN A CHALLENGING PRICING ENVIRONMENT. CO ISSUES GUIDANCE FOR Q2, SEES EPS OF 0.86-0.90 VS. 0.86 CAPITAL IQ CONSENSUS ESTIMATE SEES Q2 REVS OF 688-701 MLN VS. 679.02 MLN CAPITAL IQ CONSENSUS ESTIMATE. quotWe have operated in the midst of a prolonged industrial recession, one thaT WAS PARTICULARLY ACUTE IN OUR PRIMARY END MARKETS OF METALWORKING MANUFACTURING. WE ARE, HOWEVER, SEEING SIGNS OF GREATER OPTIMISM. AT PRESENT, IT APPEARS THAT THERE IS A LEVELING IN MANUFACTURING OCCURRING AND, IN DECEMBER, WE SAW GREATER SPENDING ON CATEGORIES THAT ARE INDICATIVE OF CUSTOMER OPTIMISM. WE ARE CERTAINLY MORE POSITIVE THAN EVEN A FEW SHORT MONTHS AGO. EVEN SO, WE WOULD NEED TO SEE SUSTAINED INCREASES IN ORDER ACTIVITY BEFORE WE DECLARE THAT THE ENVIRONMENT HAS TURNED. quot 6:49 am Asanko Gold appoints Fausto Di Trapani as CFO, effective immediately, following the resignation of Greg McCunn, who has decided to pursue other business opportunities ( AKG ). Di Trapani, a Chartered AcCOUNTANT, JOINED ASANKO IN 2012 AS EXECUTIVE: FINANCE. 6:47 AM ELI LILLY EXPANDS COLLABORATION WITH MERCK ( MRK ) to add a new study of Lillys Lartruvo with Keytruda in patients with previously treated advanced or metastatic soft tissue sarcoma ( LLY ). 6:43 am Magna provides downside guidance for FY 17 revs of 30.4-31.7 bln vs 38 bln Consensus Estimate also provides 2019 revs guidance of 43.5-46.2 bln ( MGA ) : 2017 Guidance Light Vehicle Prouction (Units)North America - 17.7 mlnEurope - 21.7 mlnTotal Production Sales of 30.4-31.7 blnCapital spending of 2 bln 2019 Guidance Light Vehicle Prouction (Units) North AMERICA - 18.4 MLN EUROPE - 22.5 MLN TOTAL PRODUCTION SALES OF 34.1-36 BLNCO STATES, quotWe believe there is potential for further margin progress by 2019.quot 6:35 am Tenneco sees FY17 revenue growth of 5 (Capital IQ consensus 4.2 over projected FY16) ( TEN ). Co announced that in 2017 the company expects to outpace light vehicle industry production by 4 percentage points, which is at the mid-point of last years estimate for outgrowing the industry in 2017. In total, Tenneco expects year-over-year revenue growth of 5. This growth assumes current industry production forecasts and is at 2016 constant currency. quotTenneco has outpaced industry production by more than 3 percentage points over the last 10 years and I am pleased that our revenue outlook for 2017 builds on this proven track record of growth with contributions from both our Clean Air and Ride Performance product lines. quot In 2018 and 2019, Tenneco expects continued revenue growth, outpacing industry production by 3 to 5 percentage points each year. These estimates also exclude the impact of currency. 6:33 AM SUPERVALU MISSES BY 0.09, MISSES ON REVS ( SVU ). Reports Q3 (Nov) earnings of 0.05 per share, excluding non-recurring items, 0.09 worse than the Capital IQ Consensus of 0.14 revenues fell 1.4 yearyear to 3 bln vs the 3.76 bln Capital IQ Consensus. Total net sales within the Wholesale segment increased 0.2 percent. Retail identical store sales were negative 5.7 percent. quotThe successful sale of Save-A-Lot early in the fourth quarter provides SUPERVALU with additional flexibility to operate and grow our business, quot said President and CEO Mark Gross. quotAdditionally, our Wholesale team has done a tremendous job delivering for our customers. It is a significant accomplishment that we increased Wholesale sales compared to last year given the sales lost at the end of fiscal 2016. Unfortunately, in our Retail segment we have not been able to overcome persistent deflation, competitive impacts, and other factors. It takes time to change customers shopping habits, but our team is dedicated to improving our results. quot 6:32 am Borg Warner guides FY17 EPS amp rev below Consensus, guides Q1 EPS in-line projects 5-7 growth from net new biz bACKLOG OVER THE NEXT 3 YEARS ( BWA ). Net new business within a range of 410 mln to 590 mln in 2017, 460 mln to 670 mln in 2018 and 500 mln to 700 MLN IN 2019.Q1 GUIDANCE:SEES EPS OF 0.81-0.85 VS. THE 0.85 CAPITAL IQ CONSENSUSORGANIC NET SALES GROWTH OF 2.5 TO 6.5 COMPARED WITH FIRST QUARTER 2016 NET SALES OF 2.27 BLN. FY17 GUIDANCE:SEES FY17 EPS BETWEEN 3.35-3.45 VS. THE 3.52 CAPITAL IQ CONSENSUS SEES REVS BETWEEN 8.81-9.04 BLN VS. THE 9.31 BLN CAPITAL IQ CONSENSUS. IMPLIES ORGANIC SALES GROWTH OF 3.5 TO 6.0 COMPARED WITH EXPECTED 2016 NET SALES OF 9.05 BLN. FOREIGN CURRENCIES ARE EXPECTED TO LOWER SALES BY 320 MLN, DUE TO THE DEPRECIATION OF THE EURO, YUAN AND POUND. THE SALE OF THE REMY LIGHT VEHICLE AFTERMARKET BUSINESS IS EXPECTED TO LOWER SALES BY EXCLUDING THE IMPACT OF WEAKER FOREIGN CURRENCIES AND THE REMY LIGHT VEHICLE AFTERMARKET SALE, NET SALES GROWTH IS EXPECTED TO BE 3.5 TO 6.0.SEES FREE CASH FLOW WITHIN A RANGE OF 450 MLN TO 500 MLN. SEES SHARE REPURCHASES OF 100 MLN. 6:30 AM GRAPHIC PACKAGING ANNOUNCES NEW 250 MLN SHARE REPURCHASE PROGRAM ( GPK ). 6:02 am China Digital TV provides a further update on the pending sale of its interests in Beijing Super TV as held by Golden Benefit TECHNOLOGY LIMITED ( STV ). PURSUANT TO THE PREVIOUSLY DISCLOSED EQUITY TRANSFER AGREEMENT DATED NOVEMBER 7, 2016 AND SUPPLEMENTAL AGREEMENT TO EQUITY TRANSFER AGREEMENT DATED DECEMBER 28, 2016, THE COMPANY HAS RECEIVED, THROUGH ITS CHINESE AFFILIATE, AN AMOUNT EQUAL TO RMB610 MILLION LESS THE PREVIOUSLY RECEIVED DEPOSIT, FROM CHANGXING BAO LI RUI XIN TECHNOLOGY CO. SUPER TV HAS ALSO COMPLETED THE CHANGE OF ITS BUSINESS REGISTRATION WITH THE BEIJING ADMINISTRATION FOR INDUSTRY AND COMMERCE, AS PROVIDED IN THE SA. PURSUANT TO THE SA, THE BUYER IS REQUIRED TO PROCEED WITH THE PROCEDURES FOR CONVERTING THE RMB610 MILLION INTO US DOLLARS AND PAYING SUCH CONVERTED AMOUNT TO AN OFFSHORE ACCOUNT DESIGNATED BY GOLDEN BENEFIT, AS SOON AS POSSIBLE BUT IN ANY EVENT NO LATER THAN SEPTEMBER 30, 2017. UNTIL THE COMPLETION OF THE CURRENCY EXCHANGE AND PAYMENT, THE AMOUNT IS REQUIRED TO BE HELD IN THE ONSHORE ACCOUNT OF THE COMPANYS CHINESE AFFILIATE. THE TRANSACTION IS EXPECTED TO CLOSE ONCE THE BUYER COVERTS THE RMB610 MILLION INTO US DOLLARS AND PAYS SUCH AMOUNT TO AN OFFSHORE ACCOUNT DESIGNATED BY GOLDEN BENEFIT. 6:01 AM ARALEZ PHARMA ANNOUNCES THAT THE USPTO HAS ISSUED PATENT COVERING YOSPRALA WHICH WILL EXPIRE IN LATE 2032 WITH POSSIBLE PATENT TERM ADJUSTMENT INTO EARLY 2033 ( ARLZ ). 5:58 am On The Wires (:WIRES). LegoChem Biosciences, based in Daejeon South Korea, announced today that the Company has entered into a research licensing agreement with Takeda (TKPYY) to evaluate next-generation antibody drug conjugate candidates. Through this agreement, Takeda will have access to LCBs proprietary ADC technology, ConjuAll. Takeda will have an exclusive option to license global rights for the project results. Clariant, a world leader in specialty chemicals, announced that it is providing total catalyst solutions for two major ammonia production plants in Indonesia, in cooperation with its licensing partner KBR (KBR). The new projects rely on KBRs process technologies combined with a complete range of Clariant catalysts for the entire ammonia production process. EDFs (ECIFY) Energies Nouvelles is announcing the commissioning of four wind farms in the United States with installed capacity totalling over 708 MW. In North America, the Group has also accelerated its solar energy expansion drive in 2016 with notably a new 150 MWac project in the United States. 5:57 am SampP futures vs fair value: 1.30. Nasdaq futures vs fair value: 5.90. 5:57 am European Markets. FTSE. 7291.98. 16.50. 0.20. DAX. 11622.62. 39.30. 0.30. 5:57 am Asian Markets. Nikkei. 19365. 63.20. 0.30. Hang Seng. 22935. 190.50. 0.80. 5:38 am On The Wires (:WIRES). Fujitsu (FJTSY) will from commence sales in Japan of FUJITSU Enterprise Application PLANTIA, an equipment maintenance management system for the manufacturing industry. PLANTIA was developed by Fujitsu Group company Fujitsu Engineering Technologies CytoSorbents (CTSO) and Fresenius Medical Care (FMS) have agreed to broaden the terms of their existing partnership and to add an expansive co-marketing agreement for CytoSorb in countries where the therapy is available today. Syngenta (SYT) has collaborated with Accenture (ACN) to design and implement a new digital logistics operating model across all modes of transportation, including sea and air freight globally and road freight in North America and Europe. Citrix Systems (CTXS) introduced GoToConference, a business video conferencing package that transforms any room into a conference room to help teams collaborate. GoToConference combines in-room hardware with GoToMeeting video conferencing in a single solution, offering a new way for teams to instantly conduct both impromptu and scheduled meetings from the confeRENCE ROOM. 4:39 AM ON THE WIRES (:WIRES). GEMALTO (GTOMY) ANNOUNCED IT IS SUPPLYING BNP PARIBAS (BNPQY) WITH MOBILE PROTECTOR, A HIGHLY SECURE SOLUTION TO PROTECT WA. AN INNOVATIVE MULTI-BRAND, OMNI-CHANNEL MOBILE WALLET THAT COMBINES PAYMENTS, SHOPPING COUPONS AND LOYALTY PROGRAMS. GEMALTOS MOBILE PROTECTOR ENCOMPASSES AN SDK, AND BOTH A CUSTOMER ENROLLMENT AND AN AUTHENTICATION SERVER. EPSON (SEKEY) IS ONCE AGAIN SETTING THE BENCHMARK FOR PROFESSIONAL IMAGING EXCELLENCE WITH THE INTRODUCTION OF THE NEW 17-INCH EPSON SURECOLOR P5000. INCORPORATING THE LATEST IMAGING TECHNOLOGIES, THE SURECOLOR P5000 RESETS THE STANDARD FOR THE DESKTOP PHOTOGRAPHY, FINE ART, GRAPHIC DESIGN, AND PROOFING MARKETS. EQUINIX (EQIX) ANNOUNCED GLOBAL FINANCIAL CLOUD INFRASTRUCTURE PROVIDER, BEEKS FINANCIAL CLOUD, HAS DEPLOYED ON EQUINIXS CLOUD EXCHANGE AS IT CONTINUES TO EXPAND ITS BUSINESS GLOBALLY. TOSHIBA CORPORATIONS (TOSBF) STORAGE amp ELECTRONIC DEVICES SOLUTIONS COMPANY ANNOUNCED THE LAUNCH OF A NEW LINE-UP OF LOW-CAPACITANCE TVS DIODES FOR USE IN HIGH-SPEED INTERFACES IN MOBILE DEVICES, INCLUDING SMARTPHONES, TABLET PCS AND WEARABLE DEVICES. THE NEW DIODES DELIVER THE INDUSTRYS LEADING-CLASS PROTECTION PERFORMANCE. 4:32 AM AIRBUS REPORTS FY16 DELIVERIES ACHIEVING TARGETS ( EADSY ) : Co reports commercial aircraft deliveries in 2016 were up for the14th year in a row, reaching a new company record of 688 aircRAFT DELIVERED TO 82 CUSTOMERS. DELIVERIES WERE MORE THAN EIGHT PERCENT HIGHER THAN THE PREVIOUS RECORD OF 635 SET IN 2015.THESE INCLUDED 545 SINGLE AISLE A320 FAMILY OF WHICH 68 WERE A320 NEO, 66 A330S, 49 A350 XWBS AND 28 A380S. OVER 40 PERCENT OF SINGLE AISLE DELIVERIES WERE THE LARGER A321 MODELS. AIRBUS ACHIEVED 731 NET ORDERS FROM 51 CUSTOMERS OF WHICH EIGHT ARE NEW. THESE INCLUDED 607 SINGLES AISLE AND 124 WIDE-BODY AIRCRAFT. AT THE END OF 2016, AIRBUS OVERALL BACKLOGSTOOD AT 6,874 AIRCRAFT VALUED AT 1,018 BILLION AT LIST PRICES 4:16 AM PEUGEOT SA REPORTS FY16 UNIT SALES INCREASED BY 5.8, TO 3,146,000 UNITS ( PEUGF ) : Co reports sales by the PSA Group increased for the third consecutive year IN 2016, SALES INCREASED BY 5.8, TO 3,146,000 UNITS THE PRODUCT OFFENSIVE IN THE PUSH TO PASS PLAN WAS LAUNCHED FOR THE PEUGEOT AND CITRON BRANDS. SUCCESSFUL COMMERCIAL LAUNCHES FOR THE NEW PEUGEOT 3008 SUV, EXPERT AND TRAVELLER, THE NEW CITRON C3, THE NEW JUMPY AND SPACETOURER. 3:20 AM ALBEMARLE PRICES OFFERINGS OF 250 MLN OF 3.000 NOTES DUE 2019 AND 350 MLN OF 4.500 NOTES DUE 2020 ( ALB ). 3:19 am Parsley Energy UPSIZES OFFERING BY 2 MLN SHARES AND PRICES 22 MLN SHARES OF COMMON STOCK FOR TOTAL PROCEEDS OF 770 MLN ( PE ). 3:17 am Integra releases Q4 and FY17 guidance sees Q4 and FY17 EPS in-line with consensus ( IART ). Co issues guidance for Q4 (Dec), sees EPS of 0.50-0.53 vs. 0.52 Capital IQ Consensus Estimate sees Q4 (Dec) revs of 256 mln vs. 263.11 mln Capital IQ Consensus Estimate (resulting in full-year 2016 revenue of 992 million, at the low end of the previously provided guidance range)Co issues guidance for FY17 (Dec), sees EPS of 1.91-1.97 vs. 1.96 Capital IQ Consensus Estimate sees FY17 (Dec) revs of 1.05-1.07 bln vs. 1.07 bln Capital IQ Consensus Estimate. 2017 Financial Guidance This preliminary 2017 guidance does not include the acquisition of Derma Sciences ( DSCI ) which has not closed. Assuming a closing date at the end of the first quarter of 2017, Integra expects the acquisition to add 65 million in revenue and to be dilutive to adjusted earnings per share by approximately three cents during 2017. The acquisition is expected to turn accretive to adjusted earnings in 2018, and to reach our return on invested capital hurdle by the end of the third year. 3:08 am Derma Sciences to be acquired by Integra LifeSciences ( IART ) for 7.00 per share ( DSCI ) : Derma Sciences ( DSCI ) announced that it has signed a definitive agreement whereby Derma Sciences will be acquired by Integra LifeSciences ( IART ) for 7.00 per share of common stock in cash, or a total of 204 million, and 32.00 per share for its outstanding shares of Series A Convertible Preferred Stock and 48.00 per share for its Series B Convertible Preferred Stock, reflecting the stated value of such preferred stock in each case. The purchase price reflects a 40 premium to tHE SHARE PRICE AS OF THE MARKET CLOSE ON JANUARY 10, 2017 AND A 45 PREMIUM TO THE 30-DAY VOLUME-WEIGHTED AVERAGE SHARE PRICE OF 4.83. INTEGRA WILL ALSO ASSUME THE CONTINGENT LIABILITIES RELATED TO THE BIOD TRANSACTION, INCLUDING THE PRODUCT REGULATORY MILESTONE PAYMENT AND BOTH THE 2017 AND 2018 GROWTH EARN-OUT PAYMENTS. THE TRANSACTION, WHICH HAS BEEN APPROVED BY THE BOARDS OF DIRECTORS OF BOTH COMPANIES, IS EXPECTED TO CLOSE IN THE FIRST QUARTER OF 2017. THE COMBINATION: EXPANDS INTEGRAS REGENERATIVE TECHNOLOGY CAPABILITIES AND ACCELERATES ITS ADVANCED WOUND CARE STRATEGY WITH THE ADDITION OF AMNIOTIC TISSUE-BASED PRODUCTS LEVERAGES ITS EXISTING SALES CHANNEL WITH THE ADDITION OF A COMPLEMENTARY LINE OF ADVANCED WOUND CARE PRODUCTS 3:06 AM ON THE WIRES (:WIRES). SOUTHERN CALIFORNIA GAS COMPANY, SUBSIDIARY OF SEMPRA ENERGY (SRE), ANNOUNCED THE COMPANY WILL BE ONE OF THE FIRST NATURAL GAS UTILITIES IN THE UNITED STATES TO INCORPORATE INNOVATIVE FIBER OPTIC CABLE TECHNOLOGY TO DETECT IMPACTS AND LEAKS ALONG ITS TRANSMISSION AND HIGH-PRESSURE PIPELINE SYSTEM. APPTIO (APTI) INTRODUCED THE NEXT GENERATION OF ITS BILL OF IT APPLICATION. WITH IT, IT LEADERS CAN NOW SHOWCASE THE SERVICES PROVIDED TO THEIR BUSINESS PARTNERS AND DEMONSTRATE THEIR VALUE ACROSS BOTH TRADITIONAL AND CLOUD-ONLY ENVIRONMENTS. 3:05 AM HOSPITALITY PROPS PRICES OFFERINGS OF 200 MLN OF 4.50 UNSECURED SENIOR NOTES DUE 2023 AND 400 MLN OF 4.95 UNSECURED SENIOR NOTES DUE 2027 ( HPT ).